Exhibit 10.1


 


This FIRST AMENDMENT
TO STANDSTILL AGREEMENT AND SECOND AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is dated as of December 15,
2019, by and among AKORN, INC., a Louisiana corporation (the “Company”), the other Loan Parties under the Loan
Agreement (as defined below), an ad hoc group of Lenders (as defined below) identified on Exhibit A hereto, which constitute
“Required Lenders” under the Loan Agreement (collectively, the “Ad Hoc Group”), and the Administrative
Agent (as defined below). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed thereto in the
Loan Agreement or the Standstill Agreement (each, as defined below).


 


WHEREAS, reference
is hereby made to that certain Loan Agreement dated as of April 17, 2014 (as the same shall have been amended, supplemented or
otherwise modified from time to time, the “Loan Agreement”), by and among the Company, the other Loan Parties,
the financial institutions from time to time parties thereto as “Lenders (collectively, the “Lenders”
and each, a “Lender”) and JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”),
pursuant to which, among other things, the Lenders have made certain loans, advances, and other financial accommodations to the
Company;


 


WHEREAS, reference
is hereby made to that certain Standstill Agreement and First Amendment to Loan Agreement dated as of May 6, 2019 (the “Standstill
Agreement”), by and among the Company, the other Loan Parties, the Administrative Agent, the Ad Hoc Group, certain other
Lenders (collectively, with the Ad Hoc Group, the “Standstill Lenders”), pursuant to which, among other things:
(a) the Standstill Lenders agreed to standstill from exercising certain remedies under the Loan Agreement in connection with the
Specific Covenants and Specific Matters (each, as defined in the Standstill Agreement); and (b) the Company, the other Loan Parties,
and the Standstill Lenders, amended the Loan Agreement as set forth therein;


 


WHEREAS, Section 13(a)
of the Standstill Agreement and Section 9.02 of the Loan Agreement permit amendment of the Standstill Agreement by the Company
with consent of Required Lenders; and


 


WHEREAS, the Company
and the Lenders party hereto (constituting Required Lenders) agree to the amendments to the Standstill Agreement as set forth herein.


 


NOW, THEREFORE, in
consideration of the premises and of the mutual covenants herein contained and for other valuable considerations, the parties hereto
agree as follows:


 


Section 1.          Definitions.
Each capitalized term used herein and not otherwise defined in this Amendment shall be defined in accordance with the Loan Agreement
and Standstill Agreement, as applicable.


 


Section 2.          Amendments
to the Standstill Agreement. The Standstill Agreement (including the schedules and exhibits thereto) is hereby amended to delete
the stricken text (indicated textually in the same manner as the following example: stricken text)
and to add the double-underlined text (indicated textually in the same manner as the following example: underlined
text) as set forth in the marked blacklined copy of the Standstill Agreement attached as Annex I hereto (which shall
be the Standstill Agreement). Said Annex I has been blacklined to show all changes from the Standstill Agreement as in effect immediately
prior to the date hereof, it being agreed that, by virtue of this Amendment upon the effectiveness hereof, any amendments or other
modifications to the Standstill Agreement prior to the date hereof that are not reflected in said Annex I shall cease to be in
effect or, as the case may be, shall be modified as set forth in said Annex I, and Annex I shall for all purposes be deemed to
constitute the Standstill Agreement.


 






     


     


    

 


Section 3.          Effectiveness.
This Amendment shall be effective on the date (the “Amendment Effective Date”) on which:


 


3.1       Delivery
of Agreement. This Amendment, duly authorized and executed by the Company, the Administrative Agent and the Standstill Lenders
(constituting the Required Lenders at such time), shall have been delivered to each of the Company, the Administrative Agent, and
the Standstill Lenders;


 


3.2       No
Default. Except for any Default or Event of Default with respect to the Specified Matters, both immediately before and after
giving effect to this Amendment, no Default or Event of Default would then exist or would result therefrom;


 


3.3       Representations
and Warranties. Except with respect to the Specified Matters, all representations and warranties of the Company and the other
Loan Parties set forth herein, in the Standstill Agreement, in the Loan Agreement, and in any other Loan Document shall be true
and correct in all material respects (or, with respect to those representations and warranties expressly limited by their terms
by materiality or material adverse effect qualifications, in all respects) as of the Amendment Effective Date as if made on such
date (except to extent that such representations and warranties expressly relate to an earlier date, in which case they shall be
true and correct in all material respects as of such date);


 


3.4       No
Material Adverse Effect. Both immediately before and after giving effect to this Amendment, no Material Adverse Effect shall
have occurred and be continuing or would result therefrom, excluding a Material Adverse Effect (if any) relating to any of the
Specified Matters;


 


3.5       Closing
Certificates. The Administrative Agent shall have received a certificate, dated as of the date hereof, of a duly authorized
officer of the Company, to the effect that, at and as of the Amendment Effective Date, both before and after giving effect to this
Amendment, (x) the conditions specified in this Section 3 have been satisfied or waived and (y) all Material Subsidiaries that
are Domestic Subsidiaries are Loan Parties as of the Amendment Effective Date (it being understood and agreed, that the Administrative
Agent may conclusively rely on such certificates as evidence of such satisfaction of the conditions specified in this Section 3);


 


3.6       Amendment
Fee. The Company shall have paid, and the Administrative Agent shall have received, for the ratable benefit of each Standstill
Lender, a one-time fee equal to 1.50% of the aggregate principal amount of the Loans of such Lender on the date hereof (the “Amendment
Fee”), which Amendment Fee shall be payable in cash on the Amendment Effective Date, and shall be deemed fully earned
when paid, shall not be refundable for any reason, and shall be payable without setoff, defense or counterclaim of any kind (and,
for the avoidance of doubt the provisions of Section 2.18(d) of the Loan Agreement do not apply to the payment of such fee (or
to the extent such provisions apply, are hereby waived in connection with the payment of the Amendment Fee));


 






    	 	2	 



     


    

 


3.7       Fees
and Expenses. The Company shall (i) pay or reimburse all reasonable and documented fees and expenses for Gibson Dunn, as legal
advisor to the Ad Hoc Group, and Greenhill, as financial advisor to the Ad Hoc Group, on the terms set forth in the Standstill
Agreement to the extent invoiced at least one (1) Business Day prior to the Amendment Effective Date and (ii) pay or reimburse
all reasonable and documented out-of-pocket fees and expenses of the Administrative Agent in connection with this Amendment and
the other Loan Documents (including reasonable out-of-pocket fees, costs, and expenses of outside counsel for the Administrative
Agent) to the extent invoiced at least one (1) Business Day prior to the Amendment Effective Date;


 


Notwithstanding the
foregoing, the Amendment Effective Date shall be deemed to have occurred on the date all conditions set forth in this Section 3
other than the condition set forth in Section 3.6 have been satisfied, so long as the condition set forth in Section 3.6 is satisfied
within one Business Day thereafter; provided that, should the Company not satisfy the condition set forth in Section 3.6
within one Business Day of the Amendment Effective Date, it shall constitute an immediate Termination Event under the Standstill
Agreement and an immediate Event of Default under the Loan Agreement;


 


For the avoidance of
doubt, the Administrative Agent is hereby authorized to and shall post this Agreement to all Public-Side Lenders and Private-Side
Lenders on the Amendment Effective Date (or as soon as practicable thereafter), giving such Public-Side and Private-Side Lenders
at least 72 hours after such posting to become Standstill Lenders for all purposes of this Agreement, including, without limitation,
entitlement to the Amendment Fee.


 


Section 4.          Entire
Agreement. This Amendment, the Standstill Agreement, the Loan Agreement, and the other Loan Documents constitute the entire
agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and
understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof.


 


Section 5.          Governing
Law; Jurisdiction; Consent to Service of Process.


 


5.1       THIS
AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF
LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICABLE OF ANY LAWS OTHER THAN THE LAWS OF THE STATE OF NEW YORK.


 


5.2       Each
party hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the
Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District
of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Amendment,
or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees
that all claims in respect of any such action or proceeding may be heard and determined in such New York State or, to the extent
permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding
shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.
Nothing in any Loan Document shall affect any right that the Administrative Agent, any Issuing Bank or any Lender may otherwise
have to bring any action or proceeding relating to any Loan Document against the Company or its properties in the courts of any
jurisdiction.


 






    	 	3	 



     


    

 


5.3       Each
party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection
that it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to any Loan
Document in any court referred to in paragraph 5.2 of this Section 5. Each of the parties hereto hereby irrevocably waives, to
the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any
such court.


 


5.4       Each
party to this Amendment irrevocably consents to service of process in the manner provided for notices in Section 13(r) of the Standstill
Agreement. Nothing in any Loan Document will affect the right of any party to this Amendment to serve process in any other manner
permitted by law.


 


Section 6.          WAIVER
OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO
A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AMENDMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO
ENTER INTO THIS AMENDMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 6.


 


Section 7.          Severability.
Any term or provision of this Amendment which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be
ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms
and provisions of this Amendment or affecting the validity or enforceability of any of the terms or provisions of this Amendment
in any other jurisdiction. If any provision of this Amendment is so broad as to be unenforceable, the provision shall be interpreted
to be only so broad as would be enforceable.


 


Section 8.          Loan
Document. This Amendment constitutes a “Loan Document” for all purposes of the Standstill Agreement, the Loan Agreement,
and the other Loan Documents.


 


Section 9.          Reaffirmation.
Each of the undersigned Loan Parties acknowledges (i) all of its obligations under the Standstill Agreement, the Loan Agreement,
and the other Loan Documents to which it is a party are hereby reaffirmed and remain in full force and effect on a continuous basis
and (ii) the execution of this Amendment shall not operate as a waiver of any right, power or remedy of the Administrative Agent,
the Standstill Lenders, or the other Lenders, constitute a waiver of any provision of any of the Loan Documents, or serve to effect
a novation of the Loan Document Obligations.


 






    	 	4	 



     


    

 


Section 10.          Lender
Representations and Warranties. Each of the undersigned Lenders hereby represents and warrants that the representations and
warranties and acknowledgements set forth herein and in the Standstill Agreement (as amended hereby) are true and correct as of
the Amendment Effective Date.


 


Section 11.          Counterparts.
This Amendment may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of
which when so executed and delivered shall be deemed to be an original, but all of which when taken together shall constitute a
single instrument. Delivery of an executed counterpart of a signature page of this Amendment by facsimile or any other electronic
transmission shall be effective as delivery of a manually executed counterpart hereof.


 


Section 12.          Headings.
The headings of this Amendment are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.


 


Section 13.          Effect
of Amendment. Each reference that is made in the Standstill Agreement or the Loan Agreement or any other Loan Document to the
Standstill Agreement or the Loan Agreement shall hereafter be construed as a reference to the Standstill Agreement and/or Loan
Agreement, as amended hereby. Except as herein otherwise specifically provided, all provisions of the Standstill Agreement and
the Loan Agreement shall remain in full force and effect and be unaffected hereby and this Amendment will not by implication or
otherwise alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained
in the Standstill Agreement or the Loan Agreement or any other provision of the Standstill Agreement, the Loan Agreement, or any
other Loan Document, all of which are ratified and affirmed in all respects and will continue in full force and effect. For the
avoidance of doubt, on and after the Amendment Effective Date, this Amendment shall for all purposes constitute a Loan Document.


 


Section 14.          Direction
to the Administrative Agent; Indemnity. Each Lender party hereto hereby consents, authorizes and directs the Administrative
Agent to execute and deliver this Amendment and to take the actions contemplated herein. Each Standstill Party confirms and agrees
that (i) the Administrative Agent is only entering into this Amendment at the direction of the Required Lenders, (ii) subject to
the terms of the Loan Agreement and the other Loan Documents (including this Amendment), any action or inaction taken hereunder
by the Administrative Agent shall be at the express direction of the Required Lenders (including, without limitation, any determination
that a Default, Event of Default, and/or Standstill Event of Default has occurred and/or that the Standstill Period has ended)
and (iii) the indemnification provisions set forth in the Loan Agreement and the other Loan Documents (including, without limitation,
the indemnification provisions set forth in Sections 9.03(b) and 9.03(c) of the Loan Agreement) shall apply to actions taken by
the Administrative Agent in connection with this Amendment.


 


[Signature Pages to Follow]


 






    	 	5	 



     


    

 


IN WITNESS WHEREOF,
this Amendment has been executed by the parties hereto as of the date first written above.


 


	 	THE COMPANY:
	 	 
	 	AKORN, INC.
	 	 
	 	 
	 	By  	/s/ Duane Portwood
	 	 	Name:	Duane Portwood
	 	 	Title:	Chief Financial Officer
	 	 	 
	 	 	 
	 	OTHER LOAN PARTIES:
	 	 
	 	ADVANCED VISION RESEARCH, INC.
	 	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	AKORN (NEW JERSEY), INC.
	 	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	AKORN ANIMAL HEALTH, INC.
	 	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	AKORN OPHTHALMICS, INC.
	 	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	AKORN SALES, INC.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


	 	INSPIRE PHARMACEUTICALS, INC.
	 	 
	 	 	 
	 	By  	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	OAK PHARMACEUTICALS, INC.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	HI-TECH PHARMACAL CO., INC.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	10 EDISON STREET LLC
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary of Hi-Tech Pharmacal Co., Inc. its member
	 	 	 
	 	13 EDISON STREET LLC
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary of Hi-Tech Pharmacal Co., Inc. its member
	 	 	 
	 	VPI HOLDINGS CORP.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	VPI HOLDINGS SUB, LLC
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	VERSAPHARM INCORPORATED
	 	 
	 	 	 
	 	By  	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	COVENANT PHARMA INC.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	OLTA PHARMACEUTICALS CORP.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	CLOVER PHARMACEUTICALS CORP.
	 	 
	 	 	 
	 	By	/s/ Joseph Bonaccorsi
	 	 	Name:	Joseph Bonaccorsi
	 	 	Title:	Secretary
	 	 	 
	 	 	 
	 	JPMORGAN CHASE BANK, N.A.,
	 	as Administrative Agent
	 	 
	 	 	 
	 	By	/s/ Justin Martin
	 	 	Name:	Justin Martin




	 	 	Title:	Authorized Officer




	 		 






[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 







 


	 	BlackRock Financial Management, Inc., on behalf of funds and accounts listed below:
	 	 
	 	·               Magnetite XII, LTD.
	 	·               Magnetite XIV-R, Limited
	 	·               Magnetite XV, Limited
	 	·               Magnetite XVI, Limited
	 	·               Magnetite XVII, Limited
	 	·               Magnetite XVIII, Limited
	 	·               Magnetite XIX, Limited
	 	·               Magnetite XX, Limited
	 	·               Magnetite VII, Limited
	 	·               Magnetite VIII, Limited
	 	 
	 	 
	 	By:	/s/ AnnMarie Smith
	 	 	Name:	AnnMarie Smith
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Blue Mountain Credit Alternatives Master Fund L.P.

                    By:
BlueMountain CapCapitalManagement, LLC, its investment manager

	 	 
	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel
	 	 	 
	 	 	 
	 	BlueMountain Kicking Horse Fund L.P.
	 	By: BlueMountain Capital Management, LLC, its investment manager
	 	 	 
	 	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel
	 	 	 
	 	BlueMountain Logan Opportunities Master Fund L.P.
	 	By: BlueMountain CapCapitalManagement, LLC, its investment manager
	 	 	 
	 	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel
	 	 	 
	 	 	 
	 	BlueMountain CLO XXII Ltd.
	 	
        By: BlueMountain CapCapitalManagement, LLC, its portfolio
manager

	
	 	 	 
	 	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	BlueMountain CLO 2012-2 Ltd.
	 	By: BlueMountain CapCapitalManagement,
    LLC, its portfolio manager
	
	 	 	 
	 	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel
	 	 
	 	 
	 	BlueMountain CLO 2013-1 Ltd.
	 	By: BlueMountain CLO Management, LLC, its portfolio manager
	 		 
	 	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel
	 	 
	 	 
	 	BlueMountain CLO 2014-2 Ltd.
	 	By: BlueMountain CapCapitalManagement, LLC, its portfolio manager
	 	 
	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Deputy General Counsel
	 	 
	 	 
	 	BlueMountain Fuji US CLO I Ltd.
	 	By: BlueMountain Fuji Management, LLC, its portfolio manager
	 	
	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Secretary and Counsel



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	BlueMountain Fuji US CLO II Ltd.
	 	By: BlueMountain Fuji Management, LLC, its portfolio manager
	 	 
	 	 
	 	By	/s/ David M. O’Mara
	 	 	Name:	David M. O’Mara
	 	 	Title:	Secretary and Counsel
	 	 
	 	 
	 	BlueMountain Fuji US CLO III Ltd.
	 	By: BlueMountain Fuji Management, LLC, its portfolio manager
	 	 
	 	 
	 	By	/s/ David M. O’Mara
	 		Name: 	David M. O’Mara
	 		Title: 	Secretary and Counsel



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CANYON-ASP FUND, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON BALANCED MASTER FUND, LTD.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYO DISTRESSED OPPORTUNITY MASTER FUND II, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON DISTRESSED OPPORTUNITY CANYON-ASP FUND III, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CANYON-SL VALUE FUND, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/
    Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON DISTRESSED TX (A), LLC
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 	 
	 	 	 
	 	By	/s/
    Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	THE CANYON VALUE REALIZATION
    MASTER FUND, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 	 
	 	 	 
	 	By	/s/
    Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON-EDOF (MASTER) L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/
    Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CANYON-GRF MAS R FUND H, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON NZ-DOF INVESTING, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	EP CANYON, LTD
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON VALUE REALIZATION MAC 18, LTD.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CANYON VALUE REALIZATION FUND, L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its investment advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	CANYON BLUE CREDIT INVESTMENT FUND L.P.
	 	 
	 	By:	Canyon Capital Advisors LLC,
	 	 	its Co-investment Advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory
	 	 
	 	 
	 	By:	Canyon Partners Real Estate LLC,
	 	 	its Co-investment Advisor
	 	 
	 	 
	 	By	/s/ Jonathan M. Kaplan
	 	 	Name:	Jonathan M. Kaplan
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CARLYLE INVESTMENT MANAGEMENT LLC
	 	 
	 	Signed for an on behalf of:
	 	 
	 	Carlyle
    Global Market Strategies CLO 2014-4R, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2014-3-R, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2014-2-R, Ltd.
	 	Carlyle
    C17 CLO, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2016-1, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2015-5, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2015-4, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2015-3, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2015-2, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2013-4, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2013-3, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2013-2, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2013-1, Ltd.
	 	Carlyle
    Global Market Strategies CLO 2012-4, Ltd
	 	Carlyle
    Global Market Strategies CLO 2012-3, Ltd.
	 	 
	 	 
	 	By	/s/
    Glori Granziano
	 	 	Name:	Glori Granziano
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 







	 	CIFC Funding 2012-II-R, Ltd.
	 	By: CIFC VS Management LLC, its Collateral Manager
	 	 
	 	 
	 	By	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2013-I, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2013-II, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 



 


	 	CIFC Funding 2013-III-R Ltd.
	 	By: CIFC VS Management LLC, as Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2013-IV, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2014, Ltd.
	 	By: CIFC Asset Management LLC, its Portfolio Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2014-III, Ltd.
	 	BY: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2014-II-R, Ltd.
	 	By: CIFC Asset Management LLC, as Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2014-IV-R, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Co-Head of Investment Research
	 	CIFC Funding 2014-V, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2015-I, Ltd.
	 	BY: CIFC Asset Management LLC, its Collateral Manager
	 	
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	CIFC Funding 2015-II, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT] 


 



     


     


    

 





	 	CIFC Funding 2015-III, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research


 


[SIGNATURE PAGE TO
AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 







	 	CIFC Funding 2015-IV, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2015-V, Ltd
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2016-I, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2017-I, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2017-II, Ltd.
	 	By: CIFC CLO Management LLC, its Collateral Manager
	 	
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2017-III, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 
	 	CIFC Funding 2017-IV, Ltd.
	 	By: CIFC CLO Management LLC, its Collateral Manager, by and on behalf of each of its series, Series M-1, Series O-1 and Series R-1
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2017-V, Ltd.
	 	By: CIFC CLO MANAGEMENT II LLC, as Collateral Manager
	 	By and on behalf of each of its series, SERIES M-1, SERIES O-1, and SERIES R-1
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 
	 	CIFC Funding 2018-I, Ltd.
	 	By: CIFC CLO MANAGEMENT II LLC, as Collateral Manager
	 	By and on behalf of each of its series, SERIES M-1, SERIES O-1, and SERIES R-1
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2018-II, Ltd.
	 	By: CIFC CLO Management II LLC, its Collateral Manager, by and on behalf of each of its series, Series M-1, Series O-1 and Series R-1
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Funding 2018-III, Ltd.
	 	 
	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 
	 	CIFC Funding 2018-IV, Ltd.
	 	By: CIFC CLO Management II LLC, as Collateral Manager
	 	By and on behalf of each of its series, SERIES M-1, SERIES O-1, and SERIES R-1
	 	 
	 	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




 


	 	CIFC Loan Opportunity Fund II, Ltd.
	 	By: CIFC Asset Management LLC, its Collateral Manager
	 	 
	 	 
	 	 	 
	 	By:	/s/ Robert Mandery
	 	 	Name:	Robert Mandery
	 	 	Title:	Co-Head of Investment Research
	 	 	 	 


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    











 


	CALIFORNIA STATE TEACHERS’ RETIREMENT SYSTEM	 
	By: Credit Suisse Asset Management, LLC, as investment manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 
	CREDIT SUISSE FLOATING RATE HIGH INCOME FUND	 
	By: Credit Suisse Asset Management, LLC, as investment advisor	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	CREDIT SUISSE ASSET MANAGEMENT INCOME FUND, INC.	 
	By: Credit Suisse Asset Management, LLC, as investment advisor	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	BENTHAM SYNDICATED LOAN FUND	 
	By: Credit Suisse Asset Management, LLC, as agent (sub-advisor) for Challenger
    Investment Services Limited, the Responsible Entity for Bentham Syndicated Loan Fund	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	BENTHAM STRATEGIC LOAN FUND	 
	By: Credit Suisse Asset Management, LLC, as Sub Advisor for Bentham Asset
    Management Pty Ltd., the agent and investment manager to Fidante Partners Limited, the trustee for Bentham Strategic Loan Fund	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 
	 	 
	THE CITY OF NEW YORK GROUP TRUST	 
	By: Credit Suisse Asset Management, LLC, as its manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	CREDIT SUISSE NOVA (LUX)	 
	By: Credit Suisse Asset Management, LLC or Credit Suisse Asset Management
    Limited, each as Co-Investment Adviser to Credit Suisse Fund Management S.A., management company for Credit Suisse Nova (Lux)	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	CREDIT SUISSE STRATEGIC INCOME FUND	 
	By: Credit Suisse Asset Management, LLC, as investment advisor	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	CREDIT SUISSE HIGH YIELD BOND FUND	 
	By: Credit Suisse Asset Management, LLC, as investment advisor	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING X, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XI, LTD	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XII, LTD.	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	MADISON PARK FUNDING XIII, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XIV, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XV, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XVII, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	MADISON PARK FUNDING XIX, LTD.	 
	By: Credit Suisse Asset Management, LLC, as collateral manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XL, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XLI, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	MADISON PARK FUNDING XLIII, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manage	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	Maryland State Retirement and Pension System B	 
	y: Credit Suisse Asset Management, LLC as manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	ONE ELEVEN FUNDING I, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	ONE ELEVEN FUNDING II, LTD.	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
		Name:	Thomas Flannery	 
		Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	ONE ELEVEN FUNDING III, LTD	 
	By: Credit Suisse Asset Management, LLC, as portfolio manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	DOLLAR SENIOR LOAN FUND, LTD.	 
	By: Credit Suisse Asset Management, LLC, as investment manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	DOLLAR SENIOR LOAN MASTER FUND II, LTD.	 
	By: Credit Suisse Asset Management, LLC, as investment manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	DOLLAR SENIOR LOAN INCOME FUND, LTD.	 
	By: Credit Suisse Asset Management, LLC, as investment manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 
	 	 	 	 
	 	 	 	 
	COPPERHILL LOAN FUND I, LLC	 
	By: Credit Suisse Asset Management, LLC, as investment manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    




	 	 	 	 
	WIND RIVER FUND LLC	 
	By: Credit Suisse Asset Management, LLC, as Investment Manager	 
	 	 
	 	 
	By:	/s/ Thomas Flannery	 
	 	Name:	Thomas Flannery	 
	 	Title:	Managing Director	 


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    









 





	 	AGF FLOATING RATE INCOME FUND
	 	 
	 	By:	EATON VANCE MANAGEMENT
	 	 	AS PORTFOLIO MANAGER
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Brighthouse Funds Trust I -
	 	Brighthouse/Eaton Vance Floating
    Rate Portfolio
	 	 
	 	By:	Eaton Vance Management
	 	 	as Investment Sub Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance CLO 2013-1 LTD.
	 	 
	 	By:	Eaton Vance Management Portfolio
    Manager
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    

 


	 	Eaton Vance CLO 2014-1R, Ltd.
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 



     


     


    

 


	 	Eaton Vance CLO 2015-1 Ltd.
	 	 
	 	By:	 Eaton Vance Management Portfolio Manager
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance CLO 2018-1, Ltd.
	 	 
	 	By:	Eaton Vance Management Portfolio
    Manager
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance CLO 2019-1, Ltd.
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance Floating-Rate Income
    Plus Fund
	 	 
	 	By:	Eaton Vance Management
	 	 	as Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance Floating-Rate 2022 Target
    Term Trust
	 	 
	 	By:	Eaton Vance Management as Investment
    Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance Senior Floating-Rate
    Trust
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Eaton Vance Floating-Rate Income
    Trust
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 





 


	 	Eaton Vance International
	 	(Cayman Islands) Floating-Rate Income Portfolio
	 	 
	 	By:	Eaton Vance Management
	 	 	as Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President


 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 



     


     


    




 


	 	Eaton Vance Senior Income Trust
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

  


	 	Eaton Vance Short Duration Diversified Income Fund
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


 


	 	Eaton Vance Institutional Senior Loan Fund
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


 


	 	Eaton Vance Institutional Senior Loan Plus Fund
	 	 
	 	By:	Eaton Vance Management
	 	 	as Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

  


	 	Eaton Vance Limited Duration Income Fund
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


 


	 	Eaton Vance Floating Rate Portfolio
	 	 
	 	By:	Boston Management and Research
	 	 	as Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


 


	 	Eatom Vance US Loan Fund 2016 a Series Trust of
	 	Global Cayman Investment Trust
	 	 
	 	By:	Eaton Vance Management
	 	 	As Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

  


	 	SENIOR DEBT PORTFOLIO
	 	 
	 	By:	Boston Management and Research
	 	 	as Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B. Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President



 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

  





	 	Eaton Vance VT Floating-Rate
Income Fund
	 	 
	 	By:	Eaton Vance Management
	 	 	as Investment Advisor
	 	 
	 	 
	 	By:	/s/ Michael B.
Botthof
	 	 	Name:	Michael B. Botthof
	 	 	Title:	Vice President





  


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 



     


     


    







 


	 	GTAA PineBridge LP
	 	 
	 	By:	PineBridgeInvestmetns LLC
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/
    Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






    	 	 	 



     


    

 


	 	South Carolina Retirement Systems Group Trust
	 	 
	 	By:	PineBridgeInvestmetns LLC
	 	 	As Investment Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


  






    	 	 	 



     


    

  


	 	CSAA Insurance Exchange
	 	 
	 	By:	PineBridgeInvestmetns LLC
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    

 


	 	PineBridge Global Opportunities DM Credit

Master Fund LP
	 	 
	 	By:	PineBridgeInvestmetns LLC
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    




 


	 	Galaxy XV CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    

 


	 	Galaxy XIX CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    

 


	 	Galaxy XX CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    




 


	 	Galaxy XXI CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manger
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    




 


	 	Galaxy XXII CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manger
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


  


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    




 


	 	Galaxy XXIII CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory


 




[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






    	 	 	 



     


    

 



 













	 	Galaxy XXIV CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory



 





[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]




 






     


     


    




 


	 	Galaxy XXVII CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory



 





[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]




 






     


     


    




 


	 	Galaxy XXVIII CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	Galaxy XXIX CLO Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	Lancashire Insurance Company
	 	 
	 	By:	PineBridge Investments Europe Limited As Investment Manager
	 	 	 
	 	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	SunAmerica Income funds- AIG Strategic Bond Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 	 
	 	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	Fire and Police Pension Fund, San Antonio
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 	 
	 	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	RLI Insurance Company
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 	 
	 	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	Portico Benefit Services
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Advisor
	 	 	 
	 	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    




 


	 	PineBridge Senior Floating Rate Income Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 	 
	 	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director







 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    





 


	 	PBI-K US Loan Master Fund 2017-7 a Series Trust of Global Cayman Investment Trust
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	 W. Jeffrey Baxter
	 	 	Title:	 Managing Director




 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	PBI Stable Loan FUnd a series trust of MYL Investmetn Trust
	 	 
	 	By:	 PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director




 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	PineBridge Senior Secured Loan Fund Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	 W. Jeffrey Baxter
	 	 	Title:	 Managing Director




 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	PineBridge SARL
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	Managing Director




 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Teachers’ Retirement System of the City of New York
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title:	 Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]



 






     


     


    

 


	 	New
    York City Police Pension Fund
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name: 	W. Jeffrey Baxter
	 	 	Title: 	Managing Director



 



[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Valic
    Company II — Strategic Bond Fund
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	 /s/ W. Jeffrey Baxter
	 	 	Name: 	W. Jeffrey Baxter
	 	 	Title:	 Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]



 






     


     


    

 


	 	IA
    Clarington Global Bond Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	W. Jeffrey Baxter
	 	 	Title: 	Managing Director



 



[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Stichting
    Blue Sky Active Fixed Income US Leveraged Loan Fund
	 	 
	 	By:	 PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	 /s/ W. Jeffrey Baxter
	 	 	Name:	 W. Jeffrey Baxter
	 	 	Title: 	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT] 



 






     


     


    

 


	 	American
    International Group, Inc. Retirement
	 	Plan
    Master Trust, Trust for Defined Benefit
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffrey Baxter
	 	 	Name:	 W. Jeffrey Baxter
	 	 	Title: 	Managing Director




 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 



 


 


 


	 	GTAA PineBridge LP
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By: 	/s/
    Andrew Meissner
	 	 	Name: 	Andrew Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 








     


     


    

 


	 	South Carolina Retirement Systems
    Group Trust
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	CSAA Insurance Exchange
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Investment Advisor
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	PineBridge Global Opportunistic
    DM Credit Master Fund LP
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	Galaxy XV CLO Ltd.
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	Galaxy XIX CLO Ltd.
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	Galaxy XX CLO Ltd.
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	Galaxy XXI CLO Ltd.
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	Galaxy XXII CLO Ltd.
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory



 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	Galaxy XXIII CLO Ltd.
	 	 
	 	By: 	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name: 	Andrew
    Meissner
	 	 	Title: 	Authorized Signatory




 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


 



 


	 	Galaxy XXIV CLO Ltd.
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By: 	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 


	 	Galaxy XXVII CLO Ltd.
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
		 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 


	 	Galaxy XXVIII CLO Ltd.
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 


	 	Galaxy XXIX CLO Ltd.
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Collateral Manager
	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 


	 	Lancashire Insurance Company
	 	 
	 	By:	PineBridge Investments Europe Limited 
	 	 	As Investment Manager
	 	 
	 	By:	/s/ Andrew Meissner
	 	 	Name:	Andrew Meissner
	 	 	Title:	Authorized Signatory





 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 


	 	SunAmerica Income Funds- AIG Strategic Bond Fund
	 	 
	 	By:	 PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


	 	Fire and Police Pension Fund, San Antonio
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]




 






     


     


    

 


	 	RLI Insurance Company
	 	 
	 	By:	 PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	 Managing Director




 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]


 






     


     


    

 


	 	Portico Benefit Services
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Advisor
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director







 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 


	 	PineBridge Senior Floating Rate Income Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	 Managing Director




 





[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL
AGREEMENT]







 






     


     


    

 



 


	 	PBI-K US Loan Master Fund 2017-7
    a Series Trust of Global Cayman Investment Trust
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/
    W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director




 


[SIGNATURE
PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	PBI Stable Loan Fund a series
    trust of MYL Investment Trust
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	PineBridge Senior Secured Loan
    Fund Ltd
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	PineBridge SARL
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Teachers’ Retirement
    System of the City of New York
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	New York City Police Pension
    Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Valic Company II - Strategic
    Bond Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	IA Clarington Global Bond Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	Its Investment Sub-Advisor
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Stichting Blue Sky Active Fixed
    Income
	 	US Leveraged Loan Fund
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	American International Group,
    Inc. Retirement Plan Master Trust, Trust for Defined Benefit
	 	 
	 	By:	PineBridge Investments LLC
	 	 	As Investment Manager
	 	 
	 	By:	/s/ W. Jeffery Baxter
	 	 	Name:	W. Jeffery Baxter
	 	 	Title:	Managing Director



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 




	 	UAW Retiree
    Medical Benefits Trust (Chrysler Separate Retiree Account)
	 	 
	 	By: State
    Street Bank and Trust Company, solely in its capacity as Trustee for UAW Retiree Medical Benefits Trust (solely for the benefit
    of the Chrysler Separate Retiree Account), as directed by PineBridge Investments LLC as Investment Manager, and not in its
    individual capacity
	 	 
	 	By: 	/s/ Chris
    Hunter
	 	 	Name: 	Chris Hunter
	 	 	Title: 	Vice President



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	UAW Retiree
    Medical Benefits Trust 
	 	(GM Separate
    Retiree Account)
	 	 
	 	By: State
    Street Bank and Trust Company, solely in its capacity as Trustee for UAW Retiree Medical Benefits Trust (solely for the benefit
    of the GM Separate Retiree Account), as directed by PineBridge Investments LLC as Investment Manager, and not in its individual
    capacity
	 	 
	 	By:	/s/ Chris
    Hunter
	 	 	Name:	Chris Hunter
	 	 	Title:	Vice President



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	UAW Retiree
    Medical Benefits Trust (Ford Separate Retiree Account)
	 	 
	 	By:	State Street
    Bank and Trust Company, solely in its capacity as Trustee for UAW Retiree Medical Benefits Trust (solely for the benefit of
    the Ford Separate Retiree Account), as directed by PineBridge Investments LLC as Investment Manager, and not in its individual
    capacity
	 	 
	 	By:	/s/ Chris
    Hunter
	 	 	Name:	Chris Hunter
	 	 	Title:	Vice President



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    

 


	 	Stonehill
    Institutional Partners, L.P.
	 	 
	 	By:	Stonehill
    Capital Management, LLC
	 	 	its investment
    adviser
	 	 
	 	By:	/s/ Michael
    Stern
	 	 	Name:	Michael
    Stern
	 	 	Title:	Partner
	 	 
	 	Stonehill
    Master Fund Limited
	 	 
	 	By:	Stonehill
    Capital Management, LLC
	 	 	its investment
    adviser
	 	 
	 	By:	/s/ Michael
    Stern
	 	 	Name:	Michael Stern
	 	 	Title:	Partner



 


[SIGNATURE PAGE
TO AMENDMENT TO STANDSTILL AGREEMENT]


 






     


     


    




 


Exhibit A


 


Ad Hoc Group


 


		1.	Eaton Vance Management






		2.	CIFC Asset Management






		3.	The Carlyle Group






		4.	Funds, accounts, and other investment vehicles managed, advised, or sub-advised by Credit Suisse Asset Management, LLC






		5.	Certain funds and accounts under management by BlackRock Financial Management, Inc. and its affiliates






		6.	Western Asset Management






		7.	GSO Capital Partners






		8.	PineBridge Investments






		9.	Stonehill Capital Management






		10.	BlueMountain Capital Management






		11.	Canyon Capital



 






     


     


    

 


ANNEX I


 






     


     


    





 


EXECUTION
VERSION


 





STANDSTILL AGREEMENT AND FIRST AMENDMENT
TO LOAN AGREEMENT





 


THIS STANDSTILL AGREEMENT
AND FIRST AMENDMENT TO LOAN AGREEMENT (this “Agreement”)1 is made as of May 6, 2019, by and among
AKORN, INC., a Louisiana corporation (the “Company”), the other Loan Parties under the Loan Agreement (as defined
below), an ad hoc group of Lenders (as defined below) identified on Exhibit A hereto, which constitute the “Required
Lenders” under the Loan Agreement (collectively, the “Ad Hoc Group”), certain other Lenders, and the Administrative
Agent (as defined below). The Administrative Agent, the Ad Hoc Group, the other Lenders party hereto (collectively, with the Ad
Hoc Group, the “Standstill Lenders”), the Company and the other Loan Parties shall be referred to collectively
as the “Standstill Parties”, and each shall be referred to individually as a “Standstill Party.”
Capitalized terms used herein and not otherwise defined shall have the meanings ascribed thereto in the Loan Agreement.


 


RECITALS


 


WHEREAS, the
Company, the other Loan Parties, the financial institutions from time to time parties thereto as “Lenders” (collectively,
the “Lenders” and each, a “Lender”) and JPMorgan Chase Bank, N.A., as administrative agent
(the “Administrative Agent”), have entered into that certain Loan Agreement dated as of April 17, 2014 (as the
same shall have been amended, supplemented or otherwise modified from time to time, the “Loan Agreement”), pursuant
to which, among other things, the Lenders have made certain loans, advances, and other financial accommodations to the Company;


 


WHEREAS, the
Standstill Lenders constitute “Required Lenders” as that term is defined under the Loan Agreement;


 


WHEREAS, the
Standstill Lenders and the Company have engaged in good faith, arms-length negotiations regarding a proposed standstill agreement
solely with respect to the Lenders’ rights and remedies under the Loan Agreement or the other Loan Documents as a result
of any alleged Event of Default arising from any: (1) alleged breach of any of the covenants
contained in Sections 5.01, 5.02, 5.03, 5.06 or 5.07 of the Loan Agreement (the “Specified Covenants”), to the
extent the facts and circumstances giving rise to any such breach (i) are publicly available as of the date
of this Agreement,First Amendment Effective Date (as defined herein), or
(ii) are not publicly available but have been disclosed in writing (x) to private side Lenders via IntraLinks; or (y) to Jones
DayGibson Dunn & Crutcher LLP (“Gibson Dunn”)2
and/or Greenhill & Co. (“Greenhill”), as legal counsel and financial advisor, respectively, to the Ad Hoc
Group (collectively, the “Ad Hoc Group Advisors”)”);
and (2) failure to enter into a Comprehensive Amendment (as defined herein) under the First Amendment (as defined herein) on or
before December 13, 2019 (such facts and circumstances described in clauses (i1)
and (ii2), (including, for the avoidance
of doubt, the existence of this Agreement) the “Specified Matters”);


 





 









		1     As
                                         amended by that certain First Amendment to Standstill Agreement and Second Amendment
                                         to Credit Agreement dated as of December 13, 2019.





		2     The
                              Ad Hoc Group was formerly represented by the Jones Day. As of October 2, 2019, the attorneys representing
                              the Ad Hoc Group withdrew from Jones Day and have joined the law firm of Gibson, Dunn & Crutcher
                              LLP, which hereinafter represents the Ad Hoc Group.



 






     


     


    

 


WHEREAS, as
a result of these negotiations (and in the case of the Administrative Agent, as a result of the direction of the Required Lenders
to the Administrative Agent set forth in Section 12 hereof), the Company and the other Loan Parties have requested, and the Standstill
Lenders have agreed, solely with respect to the Specified Matters, to enter into this Agreement solely for the Standstill Period
(as defined below), subject to and in accordance with the terms and conditions set forth herein; and


 


WHEREAS, the
Company and the other Loan Parties have further requested, and the Standstill Lenders have agreed, subject to the terms and conditions
set forth in this Agreement, to amend the Loan Agreement as set forth herein.


 


NOW, THEREFORE,
in consideration of the covenants and agreements contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, each Standstill Party, intending to be legally bound hereby, agrees as follows:


 


		1.	Incorporation of Recitals; No Waiver; No Admission of Liability.



 


		(a)	Incorporation of Recitals. The Recitals to this Agreement are hereby incorporated by reference
as fully set forth herein and the Company, the other Loan Parties, the Administrative Agent, and the Lenders acknowledge these
Recitals to be true and correct.



 


		(b)	No Waiver. Nothing in this Agreement should in any way be deemed a waiver of any Default
or Event of Default relating to any Specified Matter or any other Default, Event of Default, or term or provision of the Loan Agreement
or any of the other Loan Documents. The Administrative Agent and the Lenders have not waived or released, are not by this Agreement
waiving or releasing, and have no present intention of waiving or releasing, any Defaults or Events of Default relating to the
Specified Matters, or any other Defaults or Events of Default that may have occurred prior to the date hereof or that may occur
after the date hereof, or any remedies or rights of the Administrative Agent or the Lenders with respect thereto, all of which
are hereby reserved. Any waiver of any Defaults or Events of Default relating to the Specified Matters or any other Default or
Event of Default shall only be effective if set forth in a written instrument executed and delivered in accordance with the provisions
of Section 9.02 of the Loan Agreement.



 


		(c)	No Admission of Liability. The execution of this Agreement and the fulfillment of its terms
is not to be construed as and does not constitute an admission or absence of any right, remedy, claim, defense, liability or wrongdoing
or responsibility on the part of any Standstill Party. Entry into this Agreement shall not constitute an admission by the Company
or any other Loan Party to the occurrence or non-occurrence of a Default or Event of Default, including with respect to the Specified
Matters. The Standstill Lenders hereby acknowledge that, as of the Second Amendment Effective
Date, to the best of their knowledge, they are not aware of any potential Defaults or Events of Default other than with respect
to the Specified Covenants relating to the Specified Matters.



 






    2


     


    

 





		2.	Standstill Period. The “Standstill Period” shall mean the period of time
from the Effective Date through the earliest of (i) December 13, 2019 (such date, the “Termination
Date”),February 7, 2020 (such date, the “Termination Date”)
(provided that up to and including the Termination Date, the Company, the Ad Hoc Group, and the Ad Hoc Group Advisors shall
negotiate in good faith with respect to the terms of a Comprehensive Amendment), (ii) upon the delivery of a notice
of termination of the Standstill Period by the Required Lenders (which may be delivered in their sole discretion), the occurrence
of a Default or Event of Default under the Loan Agreement or the other Loan Documents, or (iii) upon the delivery of a notice of
termination of the Standstill Period by the Required Lenders (which may be delivered in their sole discretion), the termination
of this Agreement as a result of any breach of, or non-compliance with, any provision of this Agreement by the Company or any other
Loan Party, including without limitation any such breach or non-compliance of or with any Affirmative Covenant, Negative Covenant,
Milestone, or Other Covenant (each as defined herein) by the Company or any other Loan Party, subject, in each case, to any applicable
cure period expressly set forth herein (each, a “Standstill Event of Default”), excluding with respect to clause
(ii), for the avoidance of doubt, any Default or Event of Default relating to a Specified Matter (the foregoing period, the “Standstill
Period”). The occurrence of any one of the events described in clauses (i), (ii), and (iii) of this Section 2 shall constitute
a “Termination Event” hereunder.



 


		3.	Standstill. Subject to the terms and conditions herein set forth and in reliance upon the
Company’s and the other Loan Parties’ representations, acknowledgments, agreements and warranties herein contained,
including, without limitation, the satisfaction of the conditions precedent set forth in Section 9 herein, the Standstill Parties
agree that during the Standstill Period, neither the Administrative Agent nor the Lenders shall (i) declare, and such parties shall
be prohibited from declaring, any Event of Default under the Loan Agreement or the other Loan Documents or (ii) otherwise seek
to exercise any rights or remedies under the Loan Agreement or the other Loan Documents, in each case of clauses (i) and (ii) above,
to the extent directly relating to any Specified Matter. The Administrative Agent’s and the Lenders’ agreement to standstill
is temporary and limited in nature and shall not be deemed: (i) to preclude or prevent the Administrative Agent or the Standstill
Lenders from exercising any rights and remedies under the Loan Documents, applicable law or otherwise arising on account of (A)
any Default or Event of Default other than those with respect to the Specified Matters, (B) the Specified Matters from and after
the termination of the Standstill Period following the occurrence of a Standstill Event of Default, (C) the Specified Matters from
and after the Termination Date, or (D) the right to seek payment of attorneys’ fees, financial advisor fees, and other costs
and expenses in connection with the preparation, negotiation, execution and delivery of this Agreement and the exercise of the
rights and remedies described herein or otherwise in connection with the Loan Documents; (ii) to effect any amendment of the Loan
Agreement or any of the other Loan Documents, all of which shall remain in full force and effect in accordance with their respective
terms, as modified hereby; (iii) to constitute a waiver of any Default or Event of Default relating to the Specified Matters or
any other Default or Event of Default (whether now existing or hereafter occurring) or any term or provision of the Loan Agreement
or any of the other Loan Documents; or (iv) to establish a custom or course of dealing among any Loan Party, the Administrative
Agent and the Standstill Lenders.



 






    3


     


    

 


		4.	Termination of Agreement. Except as expressly set forth herein, this Agreement and all provisions
herein, shall terminate upon the occurrence of a Termination Event.



 


		5.	Affirmative Covenants. Until the occurrence of a Termination Event, the Company and the
other Loan Parties covenant and agree that during the Standstill Period, the Company will (the “Affirmative Covenants”):



 


		(a)	furnish monthly 3-statement financials and Key Performance Indicators (“KPI”)
reporting included in the Company’s management reporting to the Ad Hoc Group Advisors (which reporting shall include volume
and pricing for the top 30 products and plant KPIs), in each case no later than thirty (30) days
after the end of each month; ), in each case no later than thirty (30) days after
the end of each month; provided that, commencing in January 2020, the 3-statement financials shall be retroactively adjusted
to be in a format comparable to the Business Plan and the 2019 budget on a monthly basis, beginning as of September 30, 2019, and
shall include a breakdown of manufacturing costs by key components and by manufacturing facility; for the avoidance of doubt, the
retroactively adjusted financials shall be delivered no later than January 30, 2020 provided further that, beginning in
January 2020, the 3-statement financials shall be reported in a format comparable to the existing Business Plan, the 2020 Budget
(as defined herein), and the updated Business Plan;



 


		(b(b)	provide the Ad Hoc Group
Advisors operating statistics broken down by facility (e.g., production levels, capacity utilized, etc.) and plant KPIs
on a monthly basis, in each case no later than thirty (30) days after the end of each month;



 


		(c)	beginning in January 2020 with respect to December 2019 results, provide the Ad Hoc Group Advisors
pipeline reporting for each product under development, which reports shall include information with respect to (i) manufacturing
facility, (ii) product category, , (iii) estimate of filing and launch dates, (iv) estimated market size, (v) estimated competitors
at launch, (vi) projected research and development expenses, (vii) commentary on stage of development, with the Company to use
reasonable efforts to provide key open workstreams and estimated milestones for FDA filing, and (viii) primary development facility,
if applicable; provided that projected revenue for products under development shall be provided with the Business Plan;
provided further that any molecules names appearing therein may be redacted;



 


		(d)	beginning with the first month following the delivery of the Business Plan (as defined herein),
furnish, by the tenth (10) Business Day of each month, monthly reports regarding pending Abbreviated New Drug Applications (“ANDAs”)
to the Ad Hoc Group Advisors, which reports shall include ANDAs submitted to the FDA (as defined below) and the status of FDA approvals
with respect thereto, estimated market size and known competitor information for each such ANDA, and a good faith estimate of the
timing of the approval of each such ANDA and related competitive approvals; provided that any molecules names appearing
therein may be redacted; provided further that, commencing in January 2020, such reports
shall also include  information with respect to (i) manufacturing facility, (ii) product category, (iii) estimate of filing and
launch dates, and (iv) commentary on outstanding requirements for FDA approval status; provided that projected revenue for
filed ANDAs shall be provided with the Business Plan; 



 






    4


     


    

 


		(c (e)	on or prior to the 10th calendar day of each month (or the first Business Day thereafter), conduct monthly telephone
conferences with all Lenders and permit questions from such Lenders and answers, with such telephone conferences being split into
(1) a Public-Siders and non-Public-Siders portion and (2) a solely non-Public-Siders portion; provided that (i) questions
from the Lenders shall be provided to the Company in writing no later than two (2) Business Days in advance and (ii) for the avoidance
of doubt, the Company shall not be obligated to disclose any material non-public information during the Public-Siders and non-Public-Siders
portion of such telephone conferences;



 


		(df)	on or prior to the 10th calendar day of each
month (or the first Business Day thereafter), conduct monthly telephone conferences solely with the Ad Hoc Group Advisors and
any Lenders which have become “restricted” and are then subject to non-disclosure agreements in customary form reasonably
satisfactory to the Company (collectively, the “Restricted Lenders”) with the Company and permit questions
from the Ad Hoc Group Advisors and Restricted Lenders and answers; provided that, to the extent the Restricted Lenders
monthly telephone conference is combined with the Public-Siders/non-Public-Siders telephone conference outlined in Section 5(c)
hereof, such telephone conference will include a separate portion solely for Restricted Lenders; provided further that
questions from the Ad Hoc Group Advisors and Restricted Lenders shall be provided to the Company in writing no later than two
(2) Business Days in advance;



 


		(e)	promptly(g)require
its advisors (including, for the avoidance of doubt, PJT Partners and AlixPartners (collectively, the “Company Advisors”)
to continue conducting weekly status calls with the Ad Hoc Group Advisors; provided that, in addition to the Company Advisors,
such status calls will be attended at least every other week by Jennifer Bowles or Duane Portwood; provided further that
a representative of the investment banker engaged with respect to the Akorn India Private Ltd. sale process shall provide an email
update every week to the Ad Hoc Group Advisors on the status of such sale process (or email confirmation that there have been no
material updates to such sale process);



 


		(h)	promptly, but in no event later than 48 hours after receipt,
provide the Ad Hoc Group Advisors with copies of any material (i) correspondence received from the United States Food and Drug
Administration (“FDA”), and (ii) cover letters to reports delivered to the FDA, in each case solely with regard
to any FDA Form 483 or warning letter;



 






    5


     


    

 


		(fi)	promptly upon,
but in no event later than 48 hours after receipt by the Company or the other Loan Parties, provide to the Ad Hoc Group
Advisors copies of any warning letter(s), Official Action Indicated, or OAI, statuses, or similar regulatory actions by Swissmedic
or the Central Drugs Standard Control Organization, or CDSCO, regarding those certain manufacturing facilities operated by the
Company and its Subsidiaries in Amityville, New York, Hettlingen, Switzerland, and Paonta Sahib, Himachal Pradesh, India, and
those certain research and development centers operated by the Company and its Subsidiaries in Vernon Hills, Illinois and Cranbury,
New Jersey;



 





		(gj)	promptly upon,
but in no event later than 48 hours after preparation or receipt, provide to the Ad Hoc Group Advisors formal minutes
for any FDA meeting or call to the extent made available to, or prepared by, the Company or the other Loan Parties; provided
that the Company will be entitled to redact confidential or privileged information contained therein;



 


		(hk)	(i) on or before the 3rd Business Day of each month,
provide the Ad Hoc Group Advisors with monthly Quality System Corrective Action Plan, or QSCAP, update reports, (ii) arrange for
monthly update calls between the Ad Hoc Group Advisors and the Company’s regulatory counsel, and (iii) arrange for (A) monthly
update calls with (1) NSF Pharma Biotech (“NSF”)
and (2) The Quantic Group (“Quantic”), and (B) any other calls with the Company’s cGMP consultants
to be scheduled at the reasonable request of the Ad Hoc Group Advisors; provided that the Company shall use commercially
reasonable efforts to organize expedited calls among the Company’s third-party cGMP consultants and the Ad Hoc Group Advisors
when reasonably requested by the Ad Hoc Group Advisors;



 


		(i)	provide updates no later than the 3rd Business Day of each week
to the Ad Hoc Group Advisors regarding the ABL Credit Agreement3 refinancing
and/or extension process, including providing copies of any term sheets with respect thereto (subject to any confidentiality restrictions,
and, to the extent required by any such confidentiality restrictions, the consent of the lenders and/or other parties to any such
refinancing or extension process); 



 





		(j)	promptly provide notice to the Ad Hoc Group Advisors in the event that the Company markets
any non-traditional financing to replace or refinance the ABL Credit Agreement and provide the Standstill Lenders the opportunity
to participate in any such marketing process; and



 


		(k(l)	to the extent any third
party Quality of Earnings (“QoE”) or valuation work is completed, the Company shall (i) provide the Ad Hoc
Group Advisors regular, but in no event less frequently than weekly, updates during the drafting of such work product and (ii)
promptly, but in no event later than 48 hours after receipt, provide a copy of any final QoE or valuation reports to the Ad Hoc
Group Advisors; provided that the Company’s obligations with respect to clauses (i) and (ii) hereof, shall be subject
to approval of the third parties conducting and/or commissioning the applicable analysis; provided further that, to the
extent the Company is paying for any such analysis, the Company shall require the applicable third party to agree to share the
analysis with the Ad Hoc Group prior to any retention or work being commenced;



 





 






		3	“ABL Credit Agreement” means that certain Amended
and Restated Credit Agreement dated as of April 16, 2019, by and among the Company, the other Loan Parties party thereto, JPMorgan
Chase Bank, N.A., as administrative agent, and the lenders party thereto (as the same may be amended, supplemented or otherwise
modified from time to time).



 







    6


     


    

 


		(m)	(i) provide a weekly status update on the junior capital raise process (the “Junior
Capital Process”) or any other capital raise or other formal processes run by the Company (“Other Process”)
to the Ad Hoc Group Advisors and (ii) promptly, but in no event later than 48 hours after receipt (subject to any confidentiality
obligations therein), copies of all (A) formal process or offering materials provided  generally to participants in the Junior
Capital Process or Other Process, as applicable (which, for the avoidance of doubt, shall not be required to include individual
Q&A responses to diligence requests, unless required by the following proviso), (B) written proposals, term sheets, commitment
letters, and any other similar materials received in connection with the Junior Capital Process or Other Process, as applicable;
provided that, to the extent there are material developments (as determined in good faith by the Company) in the Junior
Capital Process or Other Process, as applicable, the Company shall provide the Ad Hoc Group Advisors with an update within 24 hours
of such material developments; and



 


		(n)	continue to retain PJT Partners and AlixPartners consistent with the terms of their respective
engagement agreements as in effect on the date hereof, or, if PJT Partners and AlixPartners are no longer retained by the Company,
such other financial and restructuring advisors reasonably acceptable to the Ad Hoc Group.



 


The failure to comply with any
of the Affirmative Covenants shall not constitute a Default or Event of Default under the Loan Agreement or the other Loan Documents,
but shall, following the Cure Period (defined below), constitute a Standstill Event of Default that permits the Required Lenders
to declare a Termination Event. “Cure Period” shall mean five (5) Business Days after the earlier of (x) the
Company’s knowledge of its breach or failure to comply or (y) notice thereof from the Administrative Agent (which notice
shall be given solely at the request of the Required Lenders).


 


		6.	Negative Covenants. Until the occurrence of a Termination Event, the Company and the other
Loan Parties covenant and agree that during the Standstill Period the Company shall not, and shall not permit any Restricted Subsidiary
to, directly or indirectly (the “Negative Covenants”):



 






    7


     


    

 


		(a)	create, incur, assume, or suffer to exist any Permitted Ratio Indebtedness pursuant to Section
6.01(l) of the Loan Agreement, (including, for the
avoidance of doubt, any asset based lending facility or cash flow supported revolver), any Indebtedness pursuant to
Section 6.01(f) of the Loan Agreement, or any Incremental Term Facilities pursuant to Section 2.09 of the Loan Agreement, Incremental
Term Loans pursuant to Section 2.09 of the Loan Agreement or Incremental Notes pursuant to Section 2.09 of the Loan Agreement or
in each case, create, incur, assume or suffer to exist, any Lien in connection with the foregoing; provided, however,
that any such Indebtedness (excluding, other than with respect to any Loans outstanding under the Loan Agreement as of the date
hereof, any refinancing of any such Indebtedness) created, incurred, assumed or in existence prior to the Effective Date pursuant
to, and in reliance on, such sections shall be permitted to remain outstanding; .
For the avoidance of doubt, the Company shall not be permitted to incur any new Indebtedness that is contractually senior in right
of payment or that is secured by Liens that would rank senior to the Liens securing the existing Loans, or that primes existing
Loans in any manner whatsoever (other than ordinary course (i) Capital Lease Obligations, (ii) trade obligations, and (iii) similar
obligations);



 


		(b)	create, incur, assume, or permit to exist any Liens:



 


		(i)	pursuant to Section 6.02(l) of the Loan Agreement securing Indebtedness or other obligations in
excess of $10 million in the aggregate; or



 


		(ii)	pursuant to Section 6.02(k) of the Loan Agreement or with respect to any Incremental Term Facilities,
Incremental Term Loans or Incremental Notes; and



 


		(iii)	arising out of Sale and Leaseback Transactions (as defined in the Loan Agreement) permitted by
Section 6.06 of the Loan Agreement in excess of $10,000,000 pursuant to Section 6.02(h) of the Loan Agreement.



 


provided, however,
that any such Liens (excluding, for the avoidance of doubt, any Liens in respect of refinancing Indebtedness prohibited under Section
6(a) hereof) created, incurred, assumed or in existence prior to the Effective Date pursuant to, and in reliance on, such sections
shall be permitted to remain in effect;


 


		(c)	purchase, hold, or acquire any investment:



 


		(i)	in Equity Interests in a non-Loan Party pursuant to Section 6.04(c) of the Loan Agreement;



 


		(ii)	constituting a loan or advance to a non-Loan Party pursuant to Section 6.04(d) of the Loan Agreement;



 


		(iii)	constituting a Guarantee of Indebtedness of a non-Loan Party pursuant to Section 6.04(e) of the
Loan Agreement;



 


		(iv)	pursuant to Section 6.04(j) of the Loan Agreement; provided that such investment shall be
permissible (x) if limited to all cash consideration or (y) in the case of any (A) out-licensing transactions or other sale of
revenue stream rights, up-front payments, milestones, royalties, profit shares, distribution fees, or similar arrangements with
respect to core assets, if consummated with the prior written consent of the Required Lenders at such time (which may be withheld
in their sole discretion), or (B) out-licensing transactions or other sale of revenue stream rights, up-front payments, milestones,
royalties, profit shares, distribution fees, or similar arrangements with respect to non-core assets if consummated with the prior
written consent of Required Lenders at such time (which consent shall not be unreasonably withheld or delayed); provided,
however, that no consent of the Required Lenders shall be required in connection with out-licensing transactions or other
sales of revenue stream rights, up-front payments, milestones, royalties, profit shares, distribution fees, or similar arrangements,
with fair market value not in excess of $5 million in the aggregate, with respect to dormant or not fully developed ANDAs and/or
products;



 






    8


     


    

 


		(v)	constituting a Permitted Acquisition pursuant to Section 6.04(l) of the Loan Agreement; provided
that (x) the Company and its Restricted Subsidiaries may consummate Drug Acquisitions in an amount not exceeding $7.5 million
in the aggregate, and (y) the Company and its Restricted Subsidiaries may consummate Permitted Acquisitions other than Drug Acquisitions
in an amount not exceeding $7.5 million in the aggregate (or, with respect to any such Permitted Acquisitions by non-Loan Parties,
not exceeding $2.5 million in the aggregate);



 


		(vi)	constituting Permitted Foreign Loans pursuant to Section 6.04(m) of the Loan Agreement; or



 


		(vii)	utilizing the Available Amount pursuant to Section 6.04(n) of the Loan Agreement.



 


provided, however,
that any investments purchased, held or acquired (or made pursuant to contractual commitments in effect) prior to the Effective
Date pursuant to, and in reliance on, such sections shall not be limited by this Section 6(c);


 


		(d)	utilize any asset sale reinvestment rights pursuant to Section 2.11(c) of the Loan Agreement;



 


		(e)	make a Discounted Voluntary Prepayment pursuant to Section 2.11(g) of the Loan Agreement or acquire
any Loans pursuant to Section 9.04(e) of the Loan Agreement; provided that such Discounted Voluntary Prepayments and acquisitions
shall be permissible if offered to all Lenders at such time;



 


		(f)	make any Extension Offers to any Lenders or enter into any Extensions with any Lenders, in each
case pursuant to Section 2.23 of the Loan Agreement; provided that such Extension Offers and Extensions shall be permissible
if offered to all Lenders at such time;



 


		(g)	declare or make, or agree to declare or make, directly or indirectly, any Restricted Payment or
prepayment of any Specified Indebtedness, in each case utilizing the Available Amount,
pursuant to Section 6.08(a) or Section 6.08(b) of the Loan Agreement other
than pursuant to Sections 6.08(a)(ii) or (a)(iii); provided that any Restricted Payments under Section 6.08(a)(ii) shall
not be permitted to be paid from Loan Parties to non-Loan Parties;



 






    9


     


    

 


		(h)	other than with respect to assets owned by Akorn India Private Limited (or the Equity Interests
therein), sell, transfer, lease, or otherwise dispose of assets pursuant to Section 6.05(h) of the Loan Agreement with an aggregate
book value in excess of $15 million; provided that, any Net Proceeds from the sale of
Akorn India Private Limited shall be utilized to prepay outstanding Loans on a pro rata basis;



 


		(i)	sell, transfer, lease, or otherwise dispose of assets pursuant to Section 6.05(e) of the Loan Agreement
or engage in Sale and Leaseback Transactions pursuant to Section 6.06 of the Loan Agreement; or



 


		(j)	without prior written consent of the Required Lenders at such time, (i) designate any Restricted
Subsidiary as an Unrestricted Subsidiary pursuant to Section 5.12 of the Loan Agreement, or otherwise create or form any Unrestricted
Subsidiary, and/or (ii) transfer any assets of the Company or any of its Restricted Subsidiaries to any Unrestricted Subsidiary,
except as otherwise permitted under the Loan Agreement (after giving effect to this Agreement).);
or



 


		(k)	without the prior written consent of the Required Lenders at such time, release any existing
Loan Guarantors from their Guarantee, otherwise release any existing Loan Guarantors from their Obligations, or release any Lien
or security interest granted by such Loan Guarantors under the Loan Documents outside of the ordinary course of business.



 


Notwithstanding the foregoing,
the Company and its Restricted Subsidiaries may incur Indebtedness of the type set forth in Section 6.01(f) of the Loan Agreement
and make investments in Equity Interests of non-Loan Parties of the type set forth in Section 6.04(c) of the Loan Agreement in
an aggregate amount not exceeding $15,000,000 in order to fund capital expenditures and operations of non-Loan Party Subsidiaries.


 


For the avoidance of doubt, any
breach of, or failure to comply with any of the Negative Covenants set forth above shall result in an immediate
Event of Default under the Loan Agreement and the Loan Documents.


 


		7.	Milestones. Until the occurrence of a Termination Event, the Company shall, or shall cause,
the following to occur by the times and dates set forth below, during the Standstill Period (the “Milestones”);
provided that any “delivery” required under the Milestones shall only require delivery to the Ad Hoc Group Advisors,
and shall be in form and scope reasonably satisfactory to the Ad Hoc Group Advisors.



 


		(a)	The(i)    Commencing
on April 18, 2019, and continuing until December 18, 2019, the Company shall deliver a 13-week cash flow forecast on
a monthly basis commencing on April 18, 2019, with each subsequent 13-week cash
flow forecast delivered on or prior to the tenth Business Day of each month. The Company shall deliver monthly variance reporting
concurrently with each delivery of the 13-week cash flow forecast, starting in May 2019.



 






    10


     


    





 


(ii)       Beginning
on January 17, 2020, the Company shall deliver 13-week cash flow forecasts every other week (with respect to the period ending
during the immediately preceding week). Beginning with the week of January 6, 2020, the Company shall deliver variance reporting
every week; provided that variance reporting subsequent to the Second Amendment Effective Date should be compared to both
the 13-week cash flow forecast provided to the Ad Hoc Group Advisors in December 2019, as well as the new cash flow forecast provided
every other week. Variances shall be measured on both a weekly and cumulative basis and the variance report shall include an MD&A
indicating which variances are permanent and which are temporary / timing oriented. 


 


(iii)      For
the avoidance of doubt, under no circumstances shall any variance reported constitute a Default, an Event of Default, a Termination
Event, or otherwise permit termination of this Agreement.


 


		(b)	The Company shall deliver a five-year business plan (the “Business Plan”) by
May 3, 2019, which business plan shall include a balance sheet, statement of cash flow, and income statement (including material
assumptions) on a monthly basis for the first year and on a quarterly basis thereafter.



 


		(c(c)	On or before January 6,
2020, the Company shall deliver to the Ad Hoc Group Advisors a detailed 2020 budget in a format consistent with the 2019 budget,
including all underlying schedules (the “2020 Budget”), with an updated version of such 2020 Budget to be provided
within 24 hours of board approval to the extent the 2020 Budget differs from what has been previously provided to the Ad Hoc Group
Advisors.



 


		(d)	On or before January 6, 2020, the Company shall deliver to the Ad Hoc Group Advisors an updated
Business Plan in a format consistent with the Business Plan delivered on May 3, 2019, with an updated version to be provided within
24 hours of board approval of such Business Plan, to the extent the updated Business Plan differs from what has been previously
provided to the Ad Hoc Group Advisors; provided that, for the avoidance of doubt, the updated Business Plan shall be accompanied
by (i) the rationale behind the inclusion of each new product included in updated Business Plan, and (ii) the rationale behind
the exclusion of each new product excluded from the updated Business Plan.



 


		(e)	PJT Partners shall provide a strategic alternatives report (the “Strategic Alternatives
Report”) by May 31, 2019 to the Ad Hoc Group Advisors, which report shall include detailed alternatives to reduce the
Lenders’ exposure.



 


		(f)	On or before January 10, 2020, the Company shall make a proposal to the Ad Hoc Group with respect
to the Comprehensive Amendment (as defined herein).



 


		(g)	On or before February 5, 2020, the Company and the Ad Hoc Group shall reach an agreement in
principle with respect to the Comprehensive Amendment.



 






    	 	11	 



     


    

 


		(h)	On or before January 8, 2020 (or such later date as agreed by the Ad Hoc Group), the Company
shall execute customary control agreements with the applicable depository banks and the Administrative Agent establishing control
over all deposit accounts, securities accounts, and investment accounts of each Loan Party (subject to certain excluded accounts
to be agreed), in each case, in form and substance reasonably acceptable to the Administrative Agent and the Ad Hoc Group.



 


		(i)	On or before January 8, 2020, the Company shall use commercially reasonable efforts to take
all necessary actions to effect the perfection of any lien on or security interest in any of the Collateral that is not perfected
as of the Second Amendment Effective Date, in each case to the extent the Company, the Administrative Agent, or the Required Lenders
have identified any required actions, including filing or recording necessary statements, filings, agreements, mortgages, or other
instruments (which, in each case, shall be in form and substance reasonably acceptable to the Administrative Agent and the Ad Hoc
Group). For the avoidance of doubt, the use of the term “commercially reasonable efforts” in this Section 7(i) shall
in no way limit, replace, or otherwise affect the Company’s existing obligations under the Loan Agreement or other Loan Documents,
including, but not limited to, the Company’s obligations under Section 5.11 of the Loan Agreement with respect to “Further
Assurances.”



 


The failure to comply with any
of the Milestones (with the exception of the Milestones contained in Sections 7(f), (g), (h), and
(i)) shall not constitute a Default or Event of Default under the Loan Agreement or the other Loan Documents, but shall,
following the Cure Period, constitute a Standstill Event of Default that permits the Required Lenders to declare a Termination
Event. Notwithstanding the foregoing, failure to comply with the Milestones in Sections 7(f), (g),
(h), and (i) shall constitute an immediate Event of Default under the Loan Agreement.


 


		8.	Other Covenants. The Company covenants and agrees that (the “Other Covenants”):



 


		(a)	Judgment or Damages Claims. During the Standstill Period, the Company shall provide
the Ad Hoc Group Advisors with written notice at least ten (10) Business Days before making any payment of any amount in excess
of $20 millionnot make any payment (whether individually or in the aggregate,
but excluding any Permitted Equity Issuance) above the amount covered or coverable by third-party insurance (from a creditworthy
insurer that has agreed in writing to provide coverage) in respect of a final, unappealable judgment, award or settlement in, or
in order to pay, post, or obtain a bond related to an appeal in, the Specified Litigation Matters (as defined below).
The Ad Hoc Group (acting through the Ad Hoc Group Advisors) shall notify the Company in writing within five (5) Business Days of
receiving the Company’s written notice if it objects to the Company’s making of such proposed payment; provided
that, if after giving effect to the making of the proposed payment, the unrestricted cash and Permitted Investments held by the
Loan Parties would be not less than the applicable amount specified on Schedule 1, the
Ad Hoc Group shall be deemed to not object, and shall not be permitted to object, to the making of the proposed payment for purposes
of this Section 8(a). If (a) the Ad Hoc Group timely objects to the proposed payment (and is permitted to do so in accordance with
the prior sentence) and (b) the Company does not agree in writing to refrain from making the proposed payment within three (3)
Business Days of its receipt of such timely objection, the Required Lenders shall be entitled to terminate the Standstill Period.
Any payment made over the timely objection of the Ad Hoc Group pursuant to this provision shall represent an Event of Default under
the Loan Agreement if making the payment has a Material Adverse Effect.) without the
prior written consent of the Required Lenders; provided that the Company shall be permitted to make payments in respect
of the Kogut Matter (as defined below) for attorney fees and related costs not to exceed two million dollars ($2,000,000).
For the avoidance of doubt, the failure to comply with the Other Covenant contained in this Section 8(a) during the Standstill
Period shall result in an immediate Event of Default under the Loan Agreement; provided
that, the Other Covenant and other provisions of this Section 8(a) shall terminate upon the occurrence of a Termination Event.
The “Specified Litigation Matters” shall mean the following litigation, and any litigation related to the following
litigation that arises out of substantially the same facts and circumstances: Akorn, Inc. v. Fresenius Kabi AG, 2018-0300-JTL
(Del. Ch.), In re Akorn, Inc. Data Integrity Securities Litigation, No. 18-cv-01713 (N.D. Ill.), In re Akorn, Inc. Derivative
Litigation, No. 18-cv-07374 (N.D. Ill.), Kogut v. Akorn, Inc., No. 646,174 (La. Dist. Ct.),.)
(the “Kogut Matter”), and In re: Generic Pharmaceuticals Pricing Antitrust Litigation, MDL
No. 2724 (E.D. Pa.).



 






    	 	12	 



     


    

 


		(b)	Comprehensive Amendment. The Company and the Required
Lenders shall each negotiate in good faith to enter into a comprehensive amendment of the Loan Agreement (the “Comprehensive
Amendment”) on or prior to the Termination Date, which comprehensive amendment shall be in form and substance acceptable
to the Required Lenders at such time, and which, in any event, shall include a modification to require affected Lender consent
for modifications to the pro rata sharing and waterfall provisions of the Loan Agreement. If a Comprehensive Amendment is not
entered into by:



 


		(i)	                November 15, 2019, then the Company shall (x) pay the Lenders a one-time fee of 0.625% of the principal
amount of the Loans outstanding on the date thereof, which fee shall be payable in kind by capitalizing and adding such amount
to the outstanding principal balance of the Loans, and (y) pledge to the Administrative Agent (for the benefit of the Secured Parties)
all Equity Interests of any CFC or FSHCO held by any Loan Parties that are not pledged as of such date; and



 


		(ii)	               December
                                         13, 2019, then February 7, 2020 (the
                                         failure“Comprehensive
                                         Amendment Deadline”); provided that (A) until the Comprehensive Amendment
                                         Deadline, the Company shall negotiate in good faith with the Ad Hoc Group Advisors and/or
                                         the Ad Hoc Group with respect to the terms of the Comprehensive Amendment, (B) the Company
                                         shall make a proposal to the Ad Hoc Group Advisors with respect to the Comprehensive
                                         Amendment by January 10, 2020, and (C) the Company and the Ad Hoc Group Advisors and/or
                                         the Ad Hoc Group will reach an agreement in principle with respect to the Comprehensive
                                         Amendment by February 5, 2020. Failure to enter into a Comprehensive Amendment
                                         or to meet any of the other requirements of this Section
                                         8(b) shall constitute an immediate Event of Default under the Loan Agreement.



 






    	 	13	 



     


    

 


Notwithstanding
anything to the contrary contained herein, the Other Covenant contained in this Section 8(b) shall survive any Termination Event.


 


		(c)	Payment of Ad Hoc Group Advisors’ Fees and Expenses. During the Standstill Period,
the Company shall pay (a) the fees and expenses of Jones DayGibson
Dunn, as counsel to the Ad Hoc Group, during the Standstill Period in
accordance with that certain Fee and Expense Reimbursement Agreement dated February 22November
15, 2019, and (b) the fees and expenses of Greenhill, as financial advisor to the Ad Hoc Group, onin
accordance with that certain engagement letter dated January 29, 2019. For the avoidance of doubt, the terms
set forth infailure to comply with the Greenhill
Engagement Letter (as defined below).Other Covenant contained in this Section 8(c)
during the Standstill Period shall result in an immediate Event of Default under the Loan Agreement



 


		9.	Conditions to the Effectiveness of this Agreement. The effectiveness of this Agreement is
subject to the satisfaction (or waiver in accordance with the terms hereof) of each of the following conditions (the date on which
such conditions are satisfied or waived, the “Effective Date”):



 


		(a)	Delivery of Agreement. This Agreement, duly authorized and executed by the Company, the
Administrative Agent and the Standstill Lenders (constituting the Required Lenders at such time), shall have been delivered to
each of the Company, the Administrative Agent, and the Standstill Lenders.



 


		(b)	No Default. Except for any Default or Event of Default with respect to the Specified Matters,
both immediately before and after giving effect to this Agreement, no Default or Event of Default would then exist or would result
therefrom.



 


		(c)	Representations and Warranties. Except with respect to the Specified Matters, all representations
and warranties of the Company and the other Loan Parties set forth herein, in the Loan Agreement and in any other Loan Document
shall be true and correct in all material respects (or, with respect to those representations and warranties expressly limited
by their terms by materiality or material adverse effect qualifications, in all respects) as of the Effective Date as if made on
such date (except to extent that such representations and warranties expressly relate to an earlier date, in which case they shall
be true and correct in all material respects as of such date).



 






    	 	14	 



     


    

 


		(d)	No Material Adverse Effect. Both immediately before and after giving effect to this Agreement,
no Material Adverse Effect shall have occurred and be continuing or would result therefrom, excluding a Material Adverse Effect
(if any) relating to any of the Specified Matters.



 


		(e)	Closing Certificate. The Administrative Agent shall have received a certificate, dated as
of the date hereof, of a duly authorized officer of the Company, to the effect that, at and as of the Effective Date, both before
and after giving effect to this Agreement, the conditions specified in this Section 9 (including clauses (b), (c), and (d) hereof)
have been satisfied or waived.



 


		(f)	Standstill Fee. The Company shall have paid, and the Administrative Agent shall have received,
for the ratable benefit of each Standstill Lender, a one-time fee equal to 1.75% of the aggregate principal amount of the Loans
of such Lender on the date hereof (the “Standstill Fee”), which Standstill Fee shall be payable in kind by capitalizing
and adding such amount to the outstanding principal balance of the Loans on the Effective Date, and shall be deemed fully earned
when paid, shall not be refundable for any reason, and shall be payable without setoff, defense or counterclaim of any kind (and
the provisions of Section 2.18(d) of the Loan Agreement are hereby waived in connection with the payment of the Standstill Fee).



 


		(g)	Fees and Expenses. The Company shall (i) execute Greenhill’s
engagement letter on the terms proposed by Greenhill on March 3, 2019 (the “Greenhill Engagement Letter”), (ii)
pay all fees and expenses accrued by Greenhill to date to the extent payable pursuant to the Greenhill Engagement Letter, (iii)
pay or reimburse all reasonable and documented fees and expenses for Jones DayGibson
Dunn, as legal advisor to the Ad Hoc Group, and Greenhill, as financial advisor to the Ad Hoc Group, on the terms set
forth herein to the extent invoiced at least one (1) Business Day prior to the Effective Date,
and (ivii) pay or reimburse all reasonable
and documented out-of-pocket fees and expenses of the Administrative Agent in connection with this Agreement and the other Loan
Documents (including reasonable out-of-pocket fees, costs, and expenses of outside counsel for the Administrative Agent) to the
extent invoiced at least one (1) Business Day prior to the Effective Date.



 


		(h)	Material Subsidiary Refresh. The Company shall (i) deliver duly executed Joinder Agreements
from all Material Subsidiaries that were not Loan Parties prior to the Effective Date, and (ii) to the extent any or all Domestic
Subsidiaries that were not Material Subsidiaries prior to the Effective Date exceed ten percent (10%) of EBITDA for the four consecutive
fiscal quarter period most recently ended or ten percent (10%) of Total Assets as of the end of such period, certify that the Company
has designated Domestic Subsidiaries as Material Subsidiaries to eliminate such excess, and any Domestic Subsidiaries so designated
shall thereafter constitute Material Subsidiaries for all purposes under the Loan Agreement and the other Loan Documents.



 






    	 	15	 



     


    

 


		10.	Representations and Warranties.



 


		(a)	Each of the Company and the other Loan Parties hereby represents and warrants to the Administrative
Agent and the Lenders that as of the Effective Date:



 


		(i)	the execution, delivery and performance of this Agreement and the Company’s and Loan Parties’
obligations hereunder have been duly authorized by all necessary corporate or limited liability company action (as applicable);



 


		(ii)	this Agreement has been duly executed and delivered by the Company and each other Loan Party and
constitutes, when executed and delivered by the other parties hereto, a legal, valid and binding obligation of the Company and
such Loan Party, enforceable against the Company or such Loan Party in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights
generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law;



 


		(iii)	no approval, consent, exemption, authorization, or other action by, or notice to, or filing with,
any Governmental Authority or any other Person is necessary or required in connection with (a) the execution, delivery or performance
by, or enforcement against, any Loan Party of this Agreement, except for (i) the approvals, consents, exemptions, authorizations,
actions, notices and filings which have been duly obtained, taken, given or made and are in full force and effect and (ii) those
approvals, consents, exemptions, authorizations or other actions, notices or filings, the failure to obtain or make which could
not reasonably be expected to have a Material Adverse Effect or (b) the exercise by any Lender of its rights under this Agreement;



 


		(iv)	except with respect to the Specified Matters, each of the representations and warranties made by
any Loan Party set forth in Article III of the Loan Agreement or in any other Loan Document is true and correct in all material
respects (unless otherwise qualified by materiality or the occurrence of a Material Adverse Effect, in which case such representation
and warranty is true and correct in all respects) as of the date hereof with the same effect as though made on and as of the date
hereof, except to the extent such representations and warranties expressly relate to earlier dates; and



 


		(v)	no Default or Event of Default has occurred and is continuing other than any Default or Event of
Default with respect to the Specified Matters.



 






    	 	16	 



     


    

 


		(b)	Each of the Standstill Parties hereby represents and warrants that each of the following statements
is true, accurate and complete as to such party as of the date hereof:



 


		(i)	such Standstill Party has carefully read and fully understands all of the terms and conditions
of this Agreement;



 


		(ii)	such Standstill Party has consulted with, or had a full and fair opportunity to consult with, an
attorney regarding the terms and conditions of this Agreement;



 


		(iii)	such Standstill Party has had a full and fair opportunity to participate in the drafting of this
Agreement;



 


		(iv)	such Standstill Party is freely, voluntarily and knowingly entering into this Agreement; and



 


		(v)	in entering into this Agreement, such Standstill Party has not relied upon any representation,
warranty, covenant or agreement not expressly set forth herein or in the other Loan Documents.



 


		11.	Amendments to the Loan Agreement. Effective as of the Effective Date, the Loan Agreement
is hereby amended as set forth below:



 


		(a)	Section 1.01 of the Loan Agreement is hereby amended to add the definitions of “First
Amendment,” “First Amendment Effective Date,” “Second Amendment,”
“Second Amendment Effective Date,” “Standstill Event of Default” and “Standstill
Period” as follows:



 


		(i)	First Amendment: that certain Standstill Agreement and First Amendment to Loan Agreement
dated as of May 6, 2019, among the Borrower, the Lenders party thereto, and the Administrative
Agent.



 


		(ii)	First Amendment Effective Date: the date on which the conditions precedent specified in
Section 9 of the First Amendment have been satisfied or waived in accordance with the terms thereof.



 


		(iii)	Second Amendment: that certain First Amendment to Standstill Agreement and Second Amendment
to Loan Agreement dated as of December 15, 2019, among the Borrower, the Lenders party thereto, and the Administrative Agent.



 


		(iv)	Second Amendment Effective Date: the date on which the conditions precedent specified in Section
3 of the Second Amendment have been satisfied or waived in accordance with the terms thereof.



 


		(iii)	Standstill Event of Default: as defined in the First Amendment.



 


		(iv)	Standstill Period: as defined in the FirstSecond
Amendment.



 






    	 	17	 



     


    

 


		(b)	Section 1.01 of the Loan Agreement is hereby amended: 



 


(i)
by amending and restating   clauses (a), (b) and (c) of the definition of
“Applicable Rate” to read as follows:


 


(a) prior to the First Amendment
Effective Date, with respect to any Eurodollar Loan or any ABR Loan, as the case may be, the applicable rate per annum set forth
below under the caption “Eurodollar Spread” or “ABR Spread”, as the case may be, based upon the Ratings
Level applicable on such date:


 


	Ratings Level	Index
Ratings

(Moody’s/S&P)	Eurodollar
 Spread	ABR Spread
	Level I	B1/B+ or higher	4.25%	3.25%
	Level II	B2/B	4.75%	3.75%
	Level III	B3/B- or lower	5.50%	4.50%




 


(b) commencing on (and including)
the First Amendment Effective Date and ending on (but excluding) the date of a Standstill Event
of DefaultSecond Amendment Effective Date, with respect to any Eurodollar
Loan or any ABR Loan, as the case may be, the applicable rate per annum set forth below under the caption “Eurodollar Spread”
or “ABR Spread”, as the case may be, based upon the Ratings Level applicable on such date:


 


	Ratings Level	Index
Ratings

(Moody’s/S&P)	Eurodollar

Spread	ABR Spread
	Level I	B1/B+ or higher	5.75%	4.75%
	Level II	B2/B	6.25%	5.25%
	Level III	B3/B- or lower	7.00%	6.00%




 


provided that 0.75% (i.e.,
75 basis points) of such Applicable Rate shall be payable in kind by capitalizing and adding such amount to the outstanding principal
balance of the Loans on the applicable Interest Payment Date);


 


and


 


(c) commencing
on (and including) the Second Amendment Effective Date and ending on (but excluding) the date of a Standstill Event of Default
(i) 9.00% per annum for any ABR Loan, and (ii) 10.00% per annum for any Eurodollar Loan; provided that 0.75% (i.e.,
75 basis points) of such Applicable Rate shall be payable in kind by capitalizing and adding such amount to the outstanding principal
balance of the Loans on the applicable Interest Payment Date); and 


 






    	 	18	 



     


    

 


(cd)
commencing on (and including) the date of a Standstill Event of Default, with respect to(i)
9.50% for any ABR Loan, and (ii) 10.50% for any Eurodollar Loan or any ABR Loan, as
the case may be, the applicable rate per annum set forth below under the caption “Eurodollar Spread” or “ABR
Spread”, as the case may be, based upon the Ratings Level applicable on such date:


 





	Ratings Level	Index Ratings
  (Moody’s/S&P)	Eurodollar Spread	ABR Spread
	Level I	B1/B+ or higher	6.25%	5.25%
	Level II	B2/B	6.75%	5.75%
	Level III	B3/B- or lower	7.50%	6.50%




 


;
provided that 1.25% (i.e., 125 basis points) of such Applicable Rate shall be payable in kind by capitalizing
and adding such amount to the outstanding principal balance of the Loans on the applicable Interest Payment Date).);
provided further that the Applicable Rate pursuant to this section (d) shall remain payable and continue to accrue following
a Termination Event and the Termination Date.


 


		(c	(ii)           by amending and restating the definition of “Interest
Payment Date” by adding the following proviso to the end of the definition:



 


“provided
that, commencing on the Second Amendment Effective Date, the Interest Payment Date for ABR Loans and Eurodollar Loans shall
be the first Business Day of each month.”


 


		(c)	Section 8.06 of the Loan Agreement is hereby amended to delete
the second sentence in its entirety and replace it with the following sentence:



 


Upon
any such resignation, the Required Lenders shall have the right to appoint a successor. 


 


		(d)	Section 2.11(a) of the Loan Agreement is hereby amended by deleting the word “and,”
prior to clause (3) and adding the following as clause (4):



 


“and (4) notwithstanding
anything in this Agreement to the contrary, in the event of any prepayment or repayment for any reason (but excluding any mandatory
prepayments under Section 2.11(c) or 2.11(d)) of the Loans during the Standstill Period (including, without limitation, upon or
after the maturity or acceleration of the Loans as a result of the occurrence of any Event of Default or otherwise, to the extent
any such acceleration is not prohibited by the terms of Section 3 of the First Amendment),
(as amended by the Second Amendment)), the Company shall pay the Lenders a premium of 0.6251.500%
of the outstanding principal of the Loans so prepaid (such premium, the “Call Protection”), calculated as of
the date of any such prepayment, repayment, or acceleration.”


 






    	 	19	 



     


    

 


		(e(d)	Section 2.13(c) of the Loan
Agreement is hereby amended and restated as follows:



 


“(c) Notwithstanding
the foregoing, upon the occurrence of any Event of Default, the Loans and all other Obligations, shall bear interest at a rate
per annum equal to 2.00% plus the Applicable Rate then in effect.”


 


		(e)	Section 8.06 of the Loan Agreement is hereby amended to delete
the second sentence in its entirety and replace it with the following sentence:



 


Upon any such
resignation, the Required Lenders shall have the right to appoint a successor. 


 


		(f)	Section 9.04(b)(i)(A) is amended and restated as follows:



 


“[Reserved];
and”


 


		(g)	Section 9.04(e) is amended and restated in its entirety as follows:



 


“(e)
Notwithstanding anything to the contrary contained herein, (x) no Lender may assign all or a portion of its rights and obligations
under this Agreement in respect of its Loans to the Borrower, any Restricted Subsidiary, or any Unrestricted Subsidiary without
the prior written consent of the Required Lenders and (y) the Borrower, any Restricted Subsidiary, or any Unrestricted Subsidiary
may not purchase or prepay Loans without the prior written consent of the Required Lenders in each case in accordance with Section
2.11(g); provided that (i) any Loans acquired by the Borrower, any Restricted Subsidiary, or any Unrestricted Subsidiary shall
be automatically retired and cancelled concurrently with the acquisition thereof, and (ii) no Default or Event of Default shall
have occurred and be continuing at the time of such assignment or sale, nor would result therefrom.”


 


		(f)	For the avoidance of doubt, the amendments set forth in this Section 11 shall survive any termination
of this Agreement.



 






    	 	20	 



     


    





 


		12.	Direction to the Administrative Agent; Indemnity. Each Lender party hereto hereby consents,
authorizes and directs the Administrative Agent to execute and deliver this Agreement and to take the actions contemplated herein.
Each Standstill Party confirms and agrees that (i) the Administrative Agent is only entering into this Agreement at the direction
of the Required Lenders, (ii) subject to the terms of the Loan Agreement and the other Loan Documents (including this Agreement),
any action or inaction taken hereunder by the Administrative Agent shall be at the express direction of the Required Lenders (including,
without limitation, any determination that a Default, Event of Default, and/or Standstill Event of Default has occurred and/or
that the Standstill Period has ended) and (iii) the indemnification provisions set forth in the Loan Agreement and the other Loan
Documents (including, without limitation, the indemnification provisions set forth in Sections 9.03(b) and 9.03(c) of the Loan
Agreement) shall apply to actions taken by the Administrative Agent in connection with this Agreement.



 


		13.	Miscellaneous.



 


		(a)	Amendment. No provision or term hereof may be amended, modified or otherwise changed except
by an instrument in writing, specifying the same, duly executed by the requisite parties in accordance with Section 9.02 of the
Loan Agreement. For the avoidance of doubt, any extension of the Termination Date hereunder shall not constitute a postponement
of any scheduled date of payment of the principal amount of any Loan, or the date for the payment of any interest, fees or other
Obligations, or a waiver or excuse of any such payment, in each case for purposes of Section 9.02(b)(iii) of the Loan Agreement.



 


		(b)	GOVERNING LAW; SUBMISSION TO JURISDICTION; SELECTION OF FORUM. THIS AGREEMENT IS TO BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED IN SUCH
STATE, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS PRINCIPLES THEREOF. Each Standstill Party hereto agrees that it shall bring
any action or proceeding in respect of any claim arising out of or related to this Agreement in any U.S. Federal (or, if such court
lacks subject matter jurisdiction, New York State) court sitting in New York, New York (or court of proper appellate jurisdiction)
(the “Chosen Courts”), and solely in connection with claims arising under this Agreement: (a) irrevocably submits
to the exclusive jurisdiction of the Chosen Courts; (b) waives any objection to laying venue in any such action or proceeding in
the Chosen Court; and (c) waives any objection that the Chosen Courts are an inconvenient forum or does not have personal jurisdiction
over any Standstill Party hereto or constitutional authority to finally adjudicate the matter; provided that, for the avoidance
of doubt, this Section 13(b) does not supersede, amend or modify the provisions of Section 9.09 of the Loan Agreement, which shall
continue to apply in accordance with its terms, including with respect to any Defaults or Events of Default asserted under the
Loan Agreement.



 


		(c)	Trial by Jury Waiver. EACH STANDSTILL PARTY HERETO IRREVOCABLY WAIVES ANY AND ALL RIGHT
TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.






 



    21


     


    




 


		(d)	Entire Agreement. This Agreement, inclusive of its schedule, represents the entire understanding
and agreement among the Standstill Parties with respect to the subject matter hereof, and supersedes all prior agreements, if any,
among them with respect thereto. Each of the Standstill Parties acknowledges that it has not relied upon any representations by
any other Standstill Party or anyone acting on behalf of any Standstill Party in entering into this Agreement.



 


		(e)	Counterparts. This Agreement may be executed in as many counterparts as may be convenient
or required. It shall not be necessary that the signature of, or on behalf of, each party, or that the signature of all persons
required to bind any party, appear on each counterpart. Signatures to this Agreement, any amendment hereof and any notice given
hereunder, transmitted by telecopy or PDF, and the photocopy of any signature page, shall be valid and effective to bind the Standstill
Party so signing. All such counterparts shall collectively constitute a single instrument.



 


		(f)	Waiver. Any provision hereof may be waived only by written instrument making specific reference
to this Agreement signed by the requisite parties in accordance with Section 9.02 of the Loan Agreement. The waiver by any Standstill
Party hereto of a breach of any provision of this Agreement shall not operate or be construed as a further or continuing waiver
of such breach or as a waiver of any other or subsequent breach. No failure on the part of any Standstill Party to exercise, and
no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial
exercise of such right, power or remedy by such Standstill Party preclude any other or further exercise thereof or the exercise
of any other right, power or remedy.



 


		(g)	Interpretation. This Agreement is the result of negotiation and, accordingly, no presumption
or burden of proof will arise with respect to any ambiguity or question of intent concerning this Agreement favoring or disfavoring
any party to this Agreement by virtue of the authorship of any provision of this Agreement.



 


		(h)	Reliance.



 


		(i)	The Loan Parties acknowledge and agree that, notwithstanding anything to the contrary set forth
in this Agreement, the Administrative Agent and the Standstill Lenders do not have, nor shall have, an obligation to: (A) subject
to the obligations set forth in Section 8(b) hereof, amend the Loan Agreement or any other Loan Document or otherwise restructure
the Obligations; (B) other than with respect to any continuation of outstanding Eurodollar Loans or any conversion of outstanding
ABR Loans into Eurodollar Loans, make any further loans, advances or extension of credit to or for the benefit of the Loan Parties,
(C) extend the Standstill Period; (D) refrain from terminating the Standstill Period upon the occurrence of any Standstill
Event of Default or (E) enter into any other instruments, agreements or documents regarding any of the same with the Loan
Parties, and that neither the Administrative Agent nor the Lenders, nor any of their respective representatives, have made any
agreements with, or commitments or representations or warranties to, the Loan Parties (either in writing or orally), other than
as expressly stated in this Agreement.



 






    22


     


    

 


		(ii)	The Loan Parties expressly understand and further agree that the Administrative Agent and the Lenders
are relying on all terms, covenants, conditions, warranties and representations set forth in this Agreement as a material inducement
to the Administrative Agent and the Lenders to enter into this Agreement and to standstill from exercising the Administrative Agent’s
and the Lenders’ rights and remedies as specifically set forth herein.



 


		(i)	Cumulative Remedies.



 


		(i)	Except as otherwise specifically provided in this Agreement, the rights, powers, authorities, remedies,
interests and benefits conferred upon the Administrative Agent and the Lenders by and as provided in this Agreement are intended
to supplement, and be in addition to (and, except as expressly set forth herein, shall not in any way replace, supersede, amend,
limit or restrict), the rights, powers, authorities, remedies, interests, and benefits conferred by the Loan Agreement and the
other Loan Documents.



 


		(ii)	No delay on the part of the Administrative Agent or the Lenders in the exercise of any power, right
or remedy under this Agreement, the Loan Agreement or any other Loan Document at any time shall operate as a waiver thereof, and
no single or partial exercise by the Administrative Agent or the Standstill Lenders of any power, right or remedy shall preclude
other or further exercise thereof or the exercise of any other power, right or remedy.



 


		(j)	Relationship. The Loan Parties agree that the relationship between the Administrative Agent
and the Lenders, on one hand, and the Loan Parties, on the other hand, is that of creditor and debtor and not that of partners
or joint venturers. This Agreement does not constitute a partnership agreement, or any other association between the Administrative
Agent, the Lenders and the Loan Parties. The Loan Parties acknowledge that the Administrative Agent and the Lenders have acted
at all times only as a creditor to the Loan Parties within the normal and usual scope of the activities normally undertaken by
a creditor and in no event have the Administrative Agent and the Lenders attempted to exercise any control over the Company or
any other Loan Party or their respective businesses or affairs. The Loan Parties further acknowledge that the Administrative Agent
and Lenders have not taken or failed to take any action under or in connection with their rights under the Loan Agreement and the
other Loan Documents that in any way or to any extent have interfered with or adversely affected the Loan Parties’ ownership
of the Collateral.



 






    23


     


    

 


		(k)	Ad Hoc Group Actions and Composition.  



 


		(i)	Any action by the Ad Hoc Group with respect to this Agreement (which, for the avoidance of doubt,
is limited to actions under Section 5(k) and Section 8(a) hereof) may be taken by members of the Ad Hoc Group with Credit Exposures
representing more than fifty percent (50%) of the Aggregate Credit Exposures of the Ad Hoc Group taken as a whole (the “Required
Ad Hoc Group Members”). Any action taken hereunder by the Required Ad Hoc Group Members shall bind all members of the
Ad Hoc Group.



 


		(ii)	In the event that, at any time on or after the Effective Date, the Ad Hoc Group does not act on
behalf of the Required Lenders, all references to the “Ad Hoc Group” in this Agreement shall be deemed to refer to
the Required Lenders.



 


		(l)	No Third Party Beneficiaries.  This Agreement is made and entered into for the
sole protection and benefit of the parties hereto and no other person or entity shall have any right of action hereon, right to
claim any right or benefit from the terms contained herein, or be deemed a third party beneficiary hereunder.



 


		(m)	Severability.  Whenever possible, each provision of this Agreement shall be interpreted
in such manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be prohibited by
or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this Agreement, it being the parties’ intention
that each and every provision of this Agreement be enforced to the fullest extent permitted by applicable law.



 


		(n)	Successors and Assigns.  This Agreement shall be binding upon, and shall inure
to the benefit of the Lenders, the Company, and the other Loan Parties and their respective successors and assigns, except that
the Company and the other Loan Parties may not assign their rights under this Agreement without the prior written consent of the
Required Lenders.



 


		(o)	Voluntary Agreement. The Loan Parties, the Administrative Agent and the Standstill Lenders
represent and warrant that they are represented by legal counsel of their choice, that they have consulted with such counsel regarding
this Agreement, that they are fully aware of the terms and provisions contained herein and of their effect and that they have voluntarily
and without coercion or duress of any kind entered into this Agreement.



 






    24


     


    

 


		(p)	Integration.  This Agreement and the instruments, agreements and documents referred
to in this Agreement shall be deemed incorporated into and made a part of the Loan Agreement and the other Loan Documents. This
Agreement shall be deemed to be a Loan Document as that term is defined in the Loan Agreement. All such instruments, agreements
and documents, and this Agreement, shall be construed as integrated and complementary of each other, and, except as otherwise specifically
provided in this Agreement, as augmenting and not restricting the Administrative Agent’s or the Lenders’ rights, remedies,
benefits and security. If after applying the foregoing an inconsistency still exists, the provisions of this Agreement shall constitute
an amendment to the Loan Agreement and shall control; provided, however, that, for the avoidance of doubt, the provisions
hereof that do not survive termination of this Agreement or the Standstill Period shall not be deemed to amend the terms of the
Loan Agreement following such termination. References in the Loan Agreement to this “Agreement,” “herein,”
“hereof” or “hereunder” or references to the Loan Agreement in any other agreement or document shall, in
each case, be deemed to refer to the Loan Agreement as amended hereby.



 


		(q)	No Novation. This Agreement shall not extinguish the Loans or other Obligations outstanding
under the Loan Agreement and/or any of the other Loan Documents as in effect prior to the effectiveness of this Agreement. Nothing
herein contained shall be construed as a substitution, novation or repayment of the Loans or other Obligations outstanding under
the Loan Agreement and/or any of the other Loan Documents as in effect prior to the effectiveness of this Agreement, all of which
shall remain outstanding in full force and effect after the effectiveness of this Agreement, as amended hereby.



 


		(r)	Notices. All notices hereunder shall be deemed given if in writing and delivered by electronic
mail, courier, or registered or certified mail (return receipt requested) to the following addresses (or at such other addresses
as shall be specified by like notice):



 


		i.	if to the Company:



 


Akorn, Inc.

1925 West Field Court, Suite 300

Lake Forest, IL 60045

Attention: Duane Portwood, Chief Financial Officer


 


Email address: duane.portwood@akorn.com


 


Copies to:


 


Cravath, Swaine & Moore LLP


825 8th Ave


New York, NY 10019 


Attention: Paul H. Zumbro; Stephen
M. Kessing


Email address: pzumbro@cravath.com; skessing@cravath.com


 


Kirkland & Ellis LLP


601 Lexington Avenue


New York, NY 10022


Attention: Patrick J.
Nash; Nicole L. Greenblatt


	Email address:	patrick.nash@kirkland.com;	 
	 	nicole.greenblatt@kirkland.com	 



 






    25


     


    

 


		ii.	if to the Ad Hoc Group:



 


Jones Day


250 Vesey Street


Gibson, Dunn & Crutcher LLP


200 Park Avenue


New York, NY 1028166


Attention: Scott J. Greenberg


Email address:


sgreenberg@jonesday.comsgreenberg@gibsondunn.com


 


		iii.	if to any other Lender party hereto, to such address as may be furnished by such Lender from time to time to each of the Standstill
Parties.



 


		iv.	if to the Administrative Agent:



 


JPMorgan Chase Bank, N.A.


10 S. Dearborn Street


9th Floor, Chicago, IL 60603


Attention: Justin Martin


Email address: justin.2.martin@jpmorgan.com


 


Copy to:


 


Latham & Watkins LLP


330 North Wabash Avenue, Suite 2800


Chicago, IL 60611


Attention: Zulf Bokhari


Email address: zulf.bokhari@lw.com


 


Any notice
given by delivery, mail (electronic or otherwise), or courier shall be effective when received.


 


[Signature Pages to Follow]


 






    26


     


    

 


IN WITNESS WHEREOF,
each of the undersigned, intending to be legally bound hereby, has executed this Agreement below effective as of the Effective
Date.


 





	 	THE COMPANY:
	 	 
	 	AKORN, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name: Duane Portwood
	 	 	Title:   Chief Financial Officer
	 	 	 
	 	 	 
	 	OTHER LOAN PARTIES:
	 	 
	 	ADVANCED VISION RESEARCH, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	AKORN (NEW JERSEY), INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	AKORN ANIMAL HEALTH, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	AKORN OPHTHALMICS, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	AKORN SALES, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 







 






    27


     


    

 





	 	INSPIRE PHARMACEUTICALS, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	 	OAK PHARMACEUTICALS, INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	HI-TECH PHARMACAL CO., INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	10 EDISON STREET LLC
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	13 EDISON STREET LLC
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	VPI HOLDINGS CORP.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	VPI HOLDINGS SUB, LLC
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:







 






    28


     


    

 





	 	VERSAPHARM INCORPORATED
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	 	COVENANT PHARMA INC.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	OLTA PHARMACEUTICALS CORP.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	CLOVER PHARMACEUTICALS CORP.
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	 	 	 
	 	JPMORGAN CHASE BANK, N.A.,
	 	as Administrative Agent
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	 	[LENDERS]
	 	 	 
	 	 	 
	 	By	 
	 	 	Name:
	 	 	Title:







 






    29


     


    

 


Exhibit A


Ad Hoc Group


 


		1.	Eaton Vance Management






		2.	CIFC Asset Management






		3.	The Carlyle Group






		4.	Funds, accounts, and other investment vehicles managed, advised, or sub-advised by Credit Suisse Asset Management, LLC






		5.	Certain funds and accounts under management by BlackRock Financial Management, Inc. and its affiliates






		6.	Western Asset Management






		7.	GSO Capital Partners






		8.	PineBridge Investments






		9.	Stonehill Capital Management






		10.	BlueMountain Capital Management






11. Whitebox
Advisors LLC


11. Canyon
Capital 


 



    30


     


    




 


Schedule 1


 


		(a)	at any time on or prior to June 30, 2019, $115 million






 


		(b)	at any time from and after July 1, 2019 and on or prior to December 13, 2019, $105 million



 






    31